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ABSTRACT 
 
Telepsychotherapy for the Treatment of Trichotillomania: 
A Randomized Controlled Trial 
by 
Eric B. Lee 
Utah State University, 2018 
 
Major Professor: Dr. Michael P. Twohig 
Department: Psychology 
 
Trichotillomania is defined as recurrent pulling of one’s hair that results in 
distress and negative effects on general functioning and quality of life. Estimates of 
trichotillomania lifetime prevalence generally range from approximately 1% to 3% and it 
is likely as common as disorders such as obsessive-compulsive disorder and agoraphobia. 
Yet, quality treatment for trichotillomania is often difficult to find as many mental health 
professionals are uninformed about the disorder and its treatment. Moreover, mental 
health services in general are inaccessible to many with estimates suggesting that 96.5 
million people do not have access to adequate services. The use of telepsychology has 
been an effective method for disseminating treatment services for a variety of mental 
health conditions. However, no research has examined the effectiveness of 
telepsychology to treat trichotillomania.  
The current study reports the results of a randomized clinical trial of Acceptance 
and Commitment Therapy Enhanced Behavior Therapy for the treatment of 
trichotillomania delivered by way of telepsychology. The study compared an active 
treatment condition (n = 12) to a waitlist control condition (n = 10). Results showed 
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significant reductions in hair pulling severity from pre- to post-treatment compared to the 
waitlist condition.  
Participants in the waitlist condition received the same treatment as participants in 
the treatment condition following the waitlist period. All participants were then combined 
to examine overall treatment effects from pre-treatment to a 12-week follow-up. The 
effect of treatment on hair pulling severity was still significant at follow-up, however the 
effect was not as strong as at post-treatment. Conversely, the effect on quality of life was 
maintained and even increased following post-treatment. Additional measures of 
psychological flexibility, perceived shame, and valued action also saw significant 
changes from pre-treatment to follow-up. The findings demonstrate that telepsychology is 
a viable option to disseminate treatment for trichotillomania. Implications, limitations, 
and future research directions are discussed. 
(131 pages) 
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CHAPTER I 
 
STATEMENT OF THE PROBLEM  
 Trichotillomania is characterized by repetitive hair pulling that leads to noticeable 
hair loss and causes significant distress and social or functional impairment (American 
Psychiatric Association, 2013). The effects of trichotillomania are often significant and 
can impair interpersonal, social, occupational, and/or academic functioning (Woods et al., 
2006a). The best estimates of the prevalence of trichotillomania range from 0.6% to 3.4% 
of adults, dependent on how restrictively one defines the disorder (Christenson, Pyle, & 
Mitchell, 1991b; Duke, Keeley, Geffken, & Storch, 2010; Stanley, Borden, Bell, & 
Wagner, 1994). This indicates that trichotillomania is likely as common as other 
psychological disorders, such as obsessive-compulsive disorder and agoraphobia. Despite 
this, trichotillomania continues to be misunderstood by many mental health professionals. 
For example, a survey of over 500 psychologists and physicians in the United States 
found that professionals are relatively uninformed about trichotillomania and its 
treatment (Marcks, Wetterneck, & Woods, 2006). Only 54% of the providers surveyed 
thought cognitive behavioral therapy was an effective treatment option for 
trichotillomania and the same amount incorrectly believed that those with 
trichotillomania experienced obsessive-like thoughts about hair pulling and that it was a 
subtype of obsessive-compulsive disorder. Additionally, the majority of the professionals 
surveyed did not have referral resources to direct those with trichotillomania to find 
quality help. 
Because of professionals’ lack of knowledge and training in this area, it can be 
difficult to find quality treatment for trichotillomania. Finding professionals who are 
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experienced and knowledgeable about trichotillomania and its treatment may be 
impossible depending on location. The United States Department of Health and Human 
Services (2014) estimated that there are approximately 4,000 Mental Health Professional 
Shortage Areas in the United States that include 96.5 million people who do not have 
access to adequate mental health services. In Utah alone, there are 37 designated Mental 
Health Professional Shortage Areas, meaning that there are an insufficient number of 
mental health professionals practicing in those areas to meet the demand of care. This 
lack of adequate mental health care at both national and state levels presents a significant 
problem for the treatment of trichotillomania in rural and urban areas.  
The problem is two-fold. There is a need for more mental health care providers 
who are knowledgeable about the treatment of trichotillomania and a need for quality 
treatments provided by these professionals to reach those suffering from trichotillomania. 
The proposition of training more mental health professionals to provide quality care for 
those with trichotillomania is one useful avenue that should be pursued, but other options 
might be pursued in concert. The problem of providing care throughout the state, 
including those Mental Health Professional Shortage Areas, can also be addressed 
through the use of technology and telehealth psychotherapy practices. 
The use of telehealth has been shown to be an effective method of treating a wide 
variety of mental health conditions including, post-traumatic stress disorder (Gros, 
Yoder, Tuerk, Lozano, & Acierno, 2011), schizophrenia (Rotondi et al., 2005), alcohol 
abuse (Frueh, Henderson, & Myrick, 2005), insomnia (Lichstein et al., 2013), Tourette’s 
syndrome (Himle, Olufs, Himle, Tucker, & Woods, 2010), agoraphobia (Alcañiz et al., 
2003), and eating disorders (Shingleton, Richards, & Thompson-Brenner, 2013). 
   3
Unfortunately, no research has been conducted on the effectiveness of telehealth to treat 
trichotillomania. 
Telehealth psychotherapy appears to be a logical choice for addressing the 
problem of areas without access to quality trichotillomania treatment. The purpose of the 
current study is to examine the effectiveness of providing evidence-based treatment for 
trichotillomania through the use of telepsychology using a randomized, waitlist-control 
design.  
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CHAPTER II 
REVIEW OF THE LITERATURE  
 
Trichotillomania 
 Trichotillomania has previously been classified as an impulse-control disorder 
(American Psychiatric Association, 2000), but is currently listed as an obsessive-
compulsive or related disorder in the Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-5; American Psychiatric Association, 2013). The 
diagnostic criteria for trichotillomania include: (a) hair loss resulting from the recurrent 
pulling out of one’s hair; (b) repeated attempts to decrease or stop hair pulling; (c) 
clinically significant distress or impairment in social, occupational, or other important 
areas of function as a result of the hair pulling behavior; (d) the hair pulling behavior is 
not better explained by another medical condition; and (e) the behavior is not better 
explained by the symptoms of another mental disorder. The dysfunctional effects or 
trichotillomania may include significant social interference, such as the inability to 
maintain close relationships with others; occupational interference, such as avoiding job 
interviews or position advancement; academic functioning, such as missing school or 
having difficulties studying due to pulling; and affective disturbances, such as depression, 
anxiety, or stress (Grant et al., 2017; Wetterneck, Woods, Norberg, & Begotka, 2006; 
Woods et al., 2006a). Additionally, those with trichotillomania generally have lower 
overall quality of life compared to healthy controls (Odlaug, Kim, & Grant, 2010). 
Functional impairment appears to be related to the severity of the hair pulling symptoms 
(Woods et al., 2006a). 
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 In addition to functional impairment, other notable physical afflictions are often 
present in trichotillomania, including follicle damage, skin infections, scalp irritation or 
bleeding, and repetitive strain injury (Duke et al., 2010; O'Sullivan, Keuthen, Jenike, & 
Gumley, 1996). Furthermore, an estimated 5 to 18 percent of those with trichotillomania 
engage in trichophagy which involves the consumption of hair after pulling (Christenson 
et al., 1991b; Schlosser, Black, Blum, & Goldstein, 1994). This can lead to formations of 
hair balls in the stomach or intestines called trichobezoars that may result in abdominal 
pain, nausea, weakness, weight loss, gastrointestinal bleeding, and even death (Bouwer & 
Stein, 1998). 
 Research suggests that trichotillomania may involve two separate processes 
related to dysregulated habitual motor patterns and dysfunctional methods for responding 
to inner experiences (Woods, Wetterneck, & Flessner, 2006c). Focused pulling functions 
as an escape from unwanted inner experiences or as a means to acquire a short-term 
pleasurable sensation. Automatic pulling appears to occur outside of conscious awareness 
and often takes place when an individual is distracted or sedentary. Current research 
indicates that the vast majority of individuals with trichotillomania engage in both 
focused and automatic pulling to some degree (Flessner et al., 2008b). However, some 
evidence indicates that there could be important differences between the groups. For 
instance, those with high levels of automatic pulling experience less stress, depression, 
and disability than those with high levels of focused pulling (Flessner, Woods, Franklin, 
Cashin, & Keuthen, 2008c; Walther, Ricketts, Conelea, & Woods, 2010). 
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Prevalence 
 The prevalence of trichotillomania is not fully known due, in part, to a lack of a 
population-wide epidemiological study. Previously used diagnostic criteria restricted 
those who met the current criteria, but did not experience tension before pulling and a 
reduction of this tension after pulling. One study found that the use of these criteria 
resulted in a prevalence rate of 0.6% in college women, while the use of the current, less 
restrictive, DSM-5 criteria produced a prevalence rate of 3.4% (Christenson et al., 
1991b). Although the lifetime prevalence is generally estimated at approximately one to 
two percent, studies have found rates that range from under one percent to as high as 13% 
(Grant & Chamberlain, 2016; King et al., 1995; Odlaug & Grant, 2010; Siddiqui, Naeem, 
Naqvi, & Ahmed, 2012). 
Cultural and Racial Considerations 
Trichotillomania is less understood, recognized, and studied than many 
psychological disorders (Woods et al., 2006b). This paucity of information is magnified 
in racial/ethnic minority populations where little research has examined the cultural 
impact of trichotillomania and considerations that should guide treatment (Hall, 2001). 
Additionally, there are currently no data on potential differences in prevalence across 
cultural groups. However, some work has been done that provides information of how 
race/ethnicity might impact those with trichotillomania and its treatment. 
For example, two studies surveyed college students to assess for differences in 
hair pulling behavior between ethnic groups. The first included 635 participants of which 
70 percent were White, 28 percent were Black, and the remaining 2 percent were from a 
variety of other ethnic groups (McCarley, Spirrison, & Ceminsky, 2002). Overall, 10.2 
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percent of the participants reported hair pulling that resulted in notable hair loss, with 
Black women reporting the highest rate (15.7%). Moreover, Black women reported 
pulling due to itchy or inflamed skin significantly more than non-Black participants. The 
authors posit that this is likely attributable to hair care procedures that include harsh heat 
and chemicals that are commonly utilized by women with coarse hair. The second study 
attempted to replicate these findings in a sample of 322 college students which were 65% 
White, 30% Black, and 4% from a variety of other ethnic groups (Dubose & Spirrison, 
2006). Consistent with the McCarley et al.’s findings, 9.3% of the participants reported 
hair pulling resulting in notable hair loss; however, unlike the previous study, no 
significant differences in hair pulling behavior was found between ethnic groups.  
A larger online study recruited 1,393 participants (93% White, 4% Black, 4% 
Hispanic/Latino) who met self-reported criteria for trichotillomania. Minority participants 
were significantly less likely to pull from eye lashes and eye brows and to report tension 
before pulling than White participants. Moreover, ethnic minority participants reported 
higher levels of interference from trichotillomania with regard to home management, 
while White participants reported higher interference with academic life. Additionally, 
ethnic minority participants reported significantly less stress resulting from their 
trichotillomania symptoms than White participants. Finally, ethnic minority participants 
were less likely than White participants to utilize treatment for trichotillomania; however, 
no significant differences were found in the effectiveness of treatment once utilized 
(Neal-Barnett et al., 2010). This finding should be considered with care, as little is 
currently understood about cultural factors that could potentially be important in the 
treatment of trichotillomania. Some work has been performed examining racial identity 
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and culture and potential correlates with trichotillomania and related symptoms (Neal-
Barnett et al., 2010; Neal-Barnett & Stadulis, 2006), but much work is needed to fully 
understand the role of these factors with regard to trichotillomania. 
Additionally, it is known that members of specific ethnic groups, notably, Black 
and Latina/o, often place emphasis and importance on the appearance of hair (Neal & 
Wilson, 1989; Neal-Barnett, Ward-Brown, Mitchell, & Krownapple, 2000; Neal‐
Barnett, Statom, & Stadulis, 2011). Moreover, physical properties of hair often differ 
across racial groups, which may affect the frequency of hair pulling behavior as well as 
the areas in which one pulls (Neal-Barnett et al., 2000). Furthermore, researchers have 
speculated that cultural messages that individuals receive about their hair could influence 
hair pulling behaviors and may affect research findings (Neal-Barnett et al., 2010). The 
variable functions that hair plays in different cultures could play a role in the 
development and maintenance of trichotillomania and might be an important 
consideration when treating the disorder.  
Sex Distribution 
The sex distribution of trichotillomania is also not well understood. Lifetime 
prevalence rates have shown that trichotillomania is likely distributed equally among men 
and women (Christenson et al., 1991b). However, women are overrepresented in clinical 
trials. For example, a review of clinic trials for trichotillomania found that on average, 
women made up 89% of the participants (Chamberlain, Menzies, Sahakian, & Fineberg, 
2007).  It appears that women seek treatment for trichotillomania more often than men. 
Some have speculated that this is due in part because hair loss is unable to simply be 
blamed by male pattern baldness, less easily hidden by shaving, and is often more 
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stigmatizing for women than for men (Chamberlain, Odlaug, Boulougouris, Fineberg, & 
Grant, 2009; Christenson, Mackenzie, & Mitchell, 1991a, 1994; Penzel, 2003). 
Treatment 
Various methods have been used to treat trichotillomania, although the limited 
literature base precludes any formal, standardized treatment modality. Pharmacotherapy 
is the most common type of treatment for trichotillomania despite limited research and 
mixed clinical outcomes (Woods et al., 2006a). One study found a tricyclic 
antidepressant (clomipramine) to outperform another tricyclic antidepressant 
(desipramine) and placebo in a randomized controlled trial (RCT; Swedo et al., 1989). 
Another found positive effects for an antipsychotic (olanzapine) compared to placebo 
(Van Ameringen, Mancini, Patterson, Bennett, & Oakman, 2010). Nevertheless, the 
majority of pharmacological studies have failed to find benefits of medication over 
placebo (Bloch, Panza, Grant, Pittenger, & Leckman, 2013; Grant, Odlaug, Schreiber, & 
Kim, 2014; Mitchell & Callies, 1991; Streichenwein & Thornby, 1995). Moreover, two 
RCTs found behavior therapy to be superior to medication (Ninan, Rothbaum, Marsteller, 
Knight, & Eccard, 2000; van Minnen, Hoogduin, Keijsers, Hellenbrand, & Hendriks, 
2003); however, it appears that in some cases medication combined with habit reversal 
training produce better outcomes than either treatment alone (Dougherty, Loh, Jenike, & 
Keuthen, 2006). Currently, behavior therapy, particularly habit reversal training, appears 
to be the most supported first-line treatment for trichotillomania (Bloch et al., 2007). 
Habit reversal training. Habit reversal training is a behavioral procedure 
originally developed for the treatment of nervous habits and tics (Azrin & Nunn, 1973). It 
has since been utilized in the treatment of various problematic behaviors including, 
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trichotillomania, skin picking, tics, stuttering, thumb sucking, and other oral habits 
(Twohig, Bluett, Morrison, & Woidneck, 2014). Azrin and Nunn’s original treatment 
package consisted of multiple components that have since been modified and simplified. 
Most current habit reversal training protocols include three primary components: 
awareness training, competing response training, and social support. Awareness training 
assists in understanding the contexts in which pulling is most likely to occur. This 
awareness of when or where the behavior may occur enables opportunities to employ 
learned therapeutic techniques in these situations. Competing response training consists 
of substituting another behavior in the place of pulling when an urge to pull occurs or the 
pulling is about to habitually occur. The competing response is often incompatible with 
the pulling (e.g., making a fist), although multiple studies have shown that this is not 
required in order to be effective (e.g., clenching knees; Sharenow, Fuqua, & 
Miltenberger, 1989; Woods et al., 1999). Finally, social support involves family members 
assisting in maintaining the treatment program through the utilization of positive 
reinforcement, encouragement, and reminders to use competing responses in triggering 
situations. 
Habit reversal training is the most extensively researched behavioral treatment for 
trichotillomania and other tic-related disorders. Over 30 controlled trials have been 
performed that examined habit reversal training for multiple disorders with both children 
and adults (Twohig, Bluett, Morrison, & Woidneck, 2014). Moreover, a recent meta-
analysis of 18 studies found habit reversal training to be effective at treating a wide range 
of disorders across varied samples (Bate, Malouff, Thorsteinsson, & Bhullar, 2011). 
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Although habit reversal training is relatively effective across a breadth of 
disorders, it fails to target internal states associated with focused pulling in 
trichotillomania. This has lead researchers to modify habit reversal training in attempts to 
better target issues such as anxiety, distress, and lack of motivation that are often present 
in trichotillomania. This modification began nearly two decades ago through the use of 
cognitive behavior therapy (CBT) to supplement traditional habit reversal training 
techniques (Lerner, Franklin, Meadows, Hembree, & Foa, 1999; Rangaswami, 1997). 
Two RCTs have since shown CBT and habit reversal training to be a promising treatment 
for trichotillomania (Ninan et al., 2000; van Minnen et al., 2003); however, modern forms 
of CBT have more recently been utilized that emphasize acceptance of distressing 
internal experiences and valued living that may better account for problematic distress 
and lack of motivation often seen in the disorder. These modern CBT approaches include 
dialectical behavior therapy (DBT; Keuthen et al., 2010b), metacognitive therapy 
(Shareh, 2017), and acceptance and commitment therapy (ACT; Twohig & Woods, 
2004). Evidence for DBT as a treatment for trichotillomania is still preliminary, having 
been examined in two case studies (Keuthen & Sprich, 2012; Welch & Kim, 2012), one 
pilot study (Keuthen et al., 2010b) and one small RCT (Keuthen et al., 2010a). Similarly, 
the evidence for metacognitive therapy for trichotillomania is limited, having been 
examined in a single RCT (Shareh, 2017). While still limited, the research on ACT as a 
treatment for trichotillomania is relatively more robust at this time, as subsequently 
described.  
Acceptance and Commitment Therapy. ACT is a modern cognitive behavior 
therapy that targets six specific processes in an attempt to promote psychological 
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flexibility, which is the ability to engage in meaningful behaviors without particular 
regard for any inner experience (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). 
Psychological flexibility is fostered by targeting core ACT processes of change: (a) 
acceptance: willingness to experience inner experiences without making attempts to 
control or change them; (b) defusion: recognizing inner experiences as simply inner 
experiences without added evaluations; (c) contact with the present moment: recognizing 
inner experiences as they are occurring without ruminating or worrying about the past or 
future; (d) self as context: not defining oneself as one’s inner experience and 
experiencing oneself as the context in which transient inner experiences occur; (e) values: 
chosen, important areas of one’s life that motivate and direct behavior; (f) committed 
action: movement that is consistent with one’s chosen values. 
At this time, the use of ACT for trichotillomania and related disorders has mostly 
consisted of the use of ACT to augment traditional behavior therapies such as habit 
reversal training. However, a few studies have examined the efficacy of ACT alone for 
treating disorders commonly thought to be similar to trichotillomania. The first was a 
small study of five participants with chronic skin picking using a multiple-baseline across 
participants design (Twohig, Hayes, & Masuda, 2006). Four of the five participants 
responded very well to treatment, reaching levels of no, or very limited skin picking at 
post-treatment; however, only one of the participants maintained these results at a three-
month follow-up. The next study used a similar protocol that examined outcomes in six 
participants with problematic internet pornography viewing (Twohig & Crosby, 2010b). 
All of the participants saw pronounced decreases in time spent viewing Internet 
pornography (85% reduction on average). These results were maintained for each 
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participant at a 3-month follow-up. Moreover, each participant saw increases in 
psychological flexibility and quality of life. A final study replicated previous findings 
utilizing ACT to treat five participants with trichotillomania (Crosby, Dehlin, Mitchell, & 
Twohig, 2012). In this study, ACT was employed at the beginning of treatment and habit 
reversal techniques were incorporated toward the end of treatment. Each of the five 
participants saw significant reductions in hair pulling before habit reversal was 
introduced, and four maintained at least half of their treatment gains at a three-month 
follow-up. These studies indicate that ACT alone can be a useful treatment for obsessive 
compulsive related disorders, including trichotillomania, but also lends credence to habit 
reversal as a supplement to ACT. Moreover, habit reversal techniques combined with 
ACT might lead to more effective treatment outcomes than either therapy alone. 
ACT-enhanced Behavior Therapy. Trichotillomania often involves both 
automatic and focused pulling and it has been suggested that the pulling is maintained by 
two separate processes (Woods et al., 2006c). Because of this, recent treatment 
approaches have targeted both processes in an attempt to improve treatment outcomes. 
ACT-enhanced Behavior Therapy was developed to target overt, automatic pulling 
through the use of behavioral techniques like habit reversal training and covert, internal 
experiences that lead to focused pulling through the use of ACT (Woods & Twohig, 
2008a). In theory, combining ACT with more traditional behavioral approaches provides 
a more comprehensive treatment that will lead to improved treatment outcomes. 
While still lacking, research on the use of ACT to enhance traditional behavior 
therapy techniques (i.e., habit reversal training and stimulus control) has been more 
thorough than simply ACT alone. An initial pilot study examined the use of an ACT-
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enhanced behavior therapy protocol on six adults with trichotillomania utilizing a 
multiple-baseline across participants design (Twohig & Woods, 2004). Four of the six 
participants reduced their hair pulling behavior significantly and three were able to 
maintain their gains at a three-month follow-up. Next, a follow-up RCT was performed 
with a larger sample size of 25, that also found significant reductions in hair pulling 
(Woods et al., 2006c). Another study examined ACT-enhanced behavior therapy with 
regard to the sequence in which the two types of therapy (i.e., ACT and habit reversal 
training) are presented with five participants with trichotillomania or skin picking 
(Flessner, Busch, Heideman, & Woods, 2008a). The researchers found that participants 
responded best when both ACT and habit reversal training were utilized, but no 
differences were seen as a result of sequencing. Finally, a recent RCT including 85 
participants compared an ACT-enhanced behavior therapy protocol to psychoeducation 
and supportive therapy and found that the ACT condition significantly outperformed the 
psychoeducation and supportive therapy condition (Woods et al., 2013). 
Other studies expanded the scope of the ACT-enhanced behavior therapy protocol 
by treating individuals with Tourette syndrome (Franklin, Best, Wilson, Loew, & 
Compton, 2011) as well as adolescents with trichotillomania (Fine et al., 2012). Both 
studies saw similar positive results as previous studies when treating these populations. 
Finally, a recent case-series study saw marked decreases in picking behavior and related 
psychosocial impairment in three of four individuals with skin picking using a similar 
ACT-enhanced behavior therapy protocol (Capriotti, Ely, Snorrason, & Woods, 2015). In 
summary, the support for ACT-enhanced behavior therapy is strong.  
 
   15
Telepsychology 
 Telehealth refers to the utilization of technology to improve the delivery of, and 
access to, health care services (Sood et al., 2007). This can be achieved through the 
employment of video communication technology, telephone, text messaging, web-based 
interventions, or self-help. Telepsychology refers to a type of telehealth that consists of 
the delivery of traditional psychological services by way of technology assisted means 
(Nelson, Bui, & Velasquez, 2011). 
 Telepsychology services have many advantages over traditional, in-person 
psychotherapy. Reduced travel times as well as transportation expenses provide cost 
saving for both the therapist and client. Moreover, telepsychology might afford those 
with debilitating levels of anxiety, depression, or shame, who might not be willing to 
attend a traditional therapy session, to receive treatment from the safety and convenience 
of their own homes (Hedman et al., 2011; Maheu, Pulier, McMenamin, & Posen, 2012b). 
 Perhaps the most important advantage telepsychology has over traditional 
services, is its ability to allow therapists to provide services to underserved areas and 
populations. These include rural areas where there are often shortages of mental health 
treatment providers as well as urban or suburban areas where more providers might be 
found, but access to quality care for less understood conditions such as trichotillomania 
might still be difficult to obtain. Telepsychology has been shown to be beneficial in 
numerous settings that are often underserved including rural areas (Harley, 2006; Savin, 
Garry, Zuccaro, & Novins, 2006; Trott & Blignault, 1998), nursing homes (Rabinowitz et 
al., 2010), corrections facilities (Leonard, 2004; Zaylor, Whitten, & Kingsley, 2000), and 
remote military locations (Grady & Melcer, 2005). Additionally, research on 
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telepsychology has provided preliminary evidence of its efficacy using a variety of 
evidence-based treatment approaches to treat a wide range of mental health disorders 
(Gros et al., 2013). Although research related to the relative efficacy of treatment by 
means of telepsychology compared to traditional face-to-face therapy is still preliminary 
the current data have found telepsychology to be roughly equivalent to traditional in-
person treatment. 
 Alongside these advantages, telepsychology presents unique challenges not 
present in traditional face-to-face therapy (Barnett & Scheetz, 2003; Maheu, Pulier, 
McMenamin, & Posen, 2012a; Ragusea & VandeCreek, 2003). First, technology and 
communication through non-traditional means can be uncomfortable for some. Clients 
might need education about the use of technology and may take time to become 
comfortable speaking to a therapist over the Internet. Therefore, rapport building might 
require more time and effort in these situations and should be accounted for. Second, 
confidentiality must now be maintained by both the therapist and the client when 
providing telepsychotherapy. It is important for the therapist to make efforts to assist 
clients in finding safe, private locations when participating in therapy. Moreover, the 
therapist is responsible to utilize technology that is secure and encrypted to assist in the 
protection of confidentiality. Finally, emergency and crisis situations must be prepared 
for and handled differently when utilizing telepsychology.  These differences should be 
discussed with clients and arrangements should be made by the therapist to be prepared 
for emergencies. For example, the therapist should be aware of the client’s local 
community resources, such as police, hospitals, and family support and have contact 
information for these resources readily available. Despite these challenges, 
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telepsychology appears to be a promising and beneficial resource that can enable greater 
access to quality psychological care to those who would otherwise seek treatment at great 
cost or forgo treatment altogether. 
 At this time, no research has examined treatment of trichotillomania using 
telepsychology. However, two studies have examined the utility of habit reversal training 
and telepsychology. The first, a pilot study, examined telepsychology delivered habit 
reversal training in children with Tourette syndrome (Himle et al., 2010). The study 
employed a multiple-baseline across participants design with three participants. Results 
were very similar to traditional, face-to-face habit reversal training trials with all 
participants demonstrating significant tic reduction at post-treatment. Additionally, 
despite the use of telepsychology, participants and parents rated the treatment as 
acceptable and the therapeutic relationship as strong. The second study used 
telepsychology and a treatment known as Comprehensive Behavioral Intervention for 
Tics, which included habit reversal training as well as other behavioral techniques (Himle 
et al., 2012). Twenty participants were randomly assigned to telepsychology or face-to-
face treatment groups. Both groups demonstrated significant results with no differences 
between groups. Moreover, no differences were found on ratings of treatment 
acceptability or therapist-client alliance. These studies provide some preliminary 
evidence that habit reversal training can be successfully delivered by way of 
telepsychology without sacrificing participant acceptability of treatment or the 
therapeutic relationship. 
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Conclusion 
 A current review of the literature on the treatment of trichotillomania reveals that 
the disorder, while relatively prevalent and disruptive, continues to be misunderstood. 
Moreover, the scant availability of informed, quality treatment providers often leads to 
improper treatment or no treatment at all. However, the treatment of trichotillomania has 
progressed and improved over the past few decades, with modern approaches better 
accounting for and targeting both the behavioral and cognitive components of the 
disorder. Specifically, ACT-enhanced behavior therapy is an evidence-based approach 
that has been shown to effectively treat trichotillomania. While treatment for 
trichotillomania has improved, access to providers who are familiar with trichotillomania 
and its treatment has not. Telepsychology appears to be a promising component to the 
solution of this problem as multiple studies have shown this to be an effect way to deliver 
treatment across a variety of psychological and medical conditions. Furthermore, habit 
reversal training has been shown to work effectively when delivered by means of 
telepsychology, providing evidence that a modern approach to treatment that builds on 
this foundation could effectively be delivered in this manner. The current study is an 
attempt to examine the feasibility of delivering ACT-enhanced behavior therapy by way 
of telepsychology through the use of a randomized controlled trial. 
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CHAPTER III 
 
METHOD  
Participants 
 Participants were recruited from university campuses, mental health providers 
throughout Utah, and via advertising on the internet. To be included in the study, 
participants were required to: (a) meet the DSM-5 criteria for trichotillomania; (b) be 
seeking treatment primarily for trichotillomania-related concerns; (c) be at least 18 years 
old; (d) reside in Utah; and (e) be a fluent English speaker. Participants were excluded 
from the study if they: (a) were currently receiving psychotherapy; (b) had started or 
changed psychotropic medication in the past 30 days; or (c) were planning to start or 
change psychotropic medication during the course of the current study.  
The majority of participants were women (86.4%), heterosexual (81.8%), and 
White (95.5%). On average, participants were 32.5 (SD = 8.3) years old. Half of the 
participants reported having been previously diagnosed with at least one psychological 
disorder. Of those, three reported two previous diagnoses. The results of the diagnostic 
interview indicated that seven (31.8%) participants met criteria for a comorbid 
psychological disorder. Six of these met criteria for a single comorbid diagnosis and one 
met criteria for four comorbid diagnoses. See Table 1 for additional participant 
characteristics. 
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Table 1 
Participant Characteristics 
  
Variable N / Mean % / SD 
Age M = 32.5 SD = 8.3 
Sex   
Male 3 13.6 
Female 19 86.4 
Sexual orientation   
       Heterosexual 18 81.8 
       Gay or lesbian 2 9.1 
       Bisexual 1 4.5 
       Other 1 4.5 
Race/ethnicity   
       White 21 95.5 
       Asian 1 4.5 
       Hispanic or Latinx 1 4.5 
Education (highest level completed)   
       High school 3 13.6 
       Some college 7 31.8 
       Bachelor’s degree 6 27.3 
       Graduate degree 6 27.3 
Marital status   
Single 6 27.3 
Married 13 59.1 
Divorced 2 9.1 
Remarried 1 4.5 
Monthly income   
$1,000 to $1,999 3 13.6 
       $2,000 to $2,999 6 27.3 
       $3,000 to $3,999 3 13.6 
       $4,000 to $4,999 1 4.5 
       $5,000 to $5,999 1 4.5 
       $6,000 to $6,999 1 4.5 
       $7,000 to $7,999 2 9.1 
       $9,000 to $9,999 2 9.1 
       More than $10,000 3 13.6 
Years that hair pulling has been a problem M = 16.3 SD = 9.7 
Previous treatments for trichotillomania   
Individual therapy 11 50.0 
Self –help 2 9.1 
Previous diagnosis (self-report)   
Depression 7 31.8 
Generalized anxiety 4 18.2 
   21
Table 1 
Participant Characteristics 
  
Variable N / Mean % / SD 
Obsessive-compulsive disorder 3 13.6 
Attention deficit/hyperactivity 2 9.1 
Post-traumatic stress disorder 2 9.1 
Panic disorder 1 4.5 
Bipolar 1 4.5 
Excoriation disorder 1 4.5 
Comorbid diagnosis (MINI)   
Persistent depressive disorder 4 18.2 
Generalized anxiety disorder 3 13.6 
Major depressive disorder 2 9.1 
Panic disorder 1 4.5 
Obsessive-compulsive disorder 1 4.5 
Post-traumatic stress disorder 1 4.5 
Current psychotropic medications   
Antidepressants 6 27.3 
Stimulant 1 4.5 
Note. MINI = The Miniature International Neuropsychiatric Interview. 
 
 A power analysis was conducted using G*Power software (Faul, Erdfelder, Lang, 
& Buchner, 2007) in order to determine the number of participants to include in the 
study. A past trial of ACT-enhanced behavior therapy for trichotillomania resulted in a 
large effect size (d = .81; Woods et al., 2006c). Therefore, a power analysis was 
performed using this same effect size, with alpha set at .05 and power at .80 specifying a 
sample of 24. At the conclusion of the recruitment period, 28 individuals were assessed 
for eligibility and 22 met requirements and participated in the study. See Figure 1 for a 
participant flowchart. 
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a One participant dropped out of the intervention following session 5 with no explanation. This 
participant did not respond to contact attempts and did not complete the mid- and post-treatment 
and follow-up assessments. b One participant did not respond to contact attempts following 
completion of the post-waitlist assessment. c Two participants dropped out of the intervention 
following sessions 7 and 8. Both stated a lack of time to continue participation in the intervention. 
The first due to an injury in the family that needed to be cared for. The second due to starting a 
new job. Both completed the post-treatment assessment. d One participant did not respond to 
contact attempts to complete the follow-up assessment. 
 
Figure 1. Participant Flowchart   
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Design 
 The effect of treatment was assessed through a randomized controlled trial. 
Participants were randomized into either a treatment or waitlist control group. An online 
random number generator was used to create a list of 30 participant identifiers that were 
randomly assigned to one of two equally sized groups. Following the intake session, 
participants were given the next available identifier and assigned to the corresponding 
group. A waitlist control group offers the benefit of each participant receiving the active 
treatment while still maintaining a notable degree of experimental control. Participants 
placed in the treatment group completed a pretreatment assessment, tracked their baseline 
hair pulling for one week, and then began the 12-week treatment. Participants in the 
waitlist group completed the same pretreatment assessment, tracked their baseline hair 
pulling for one week, and then began treatment after 12 weeks had elapsed and they had 
completed a post-waitlist assessment. All participants were also given an assessment 
following their fifth treatment session. Additional follow-up assessments were given to 
both groups 12 weeks following treatment. See Table 2 for a visual representation of the 
treatment design. 
 
Table 2.  
Assessment Schedule 
  
 Week 1 Week 5 Week 12 Week 17 Week 24 Week 36 
Treatment  Pre-treatment 
Mid-
treatment 
Post-
treatment - Follow-up - 
Waitlist Pre-treatment - Post-waitlist 
Mid-
treatment 
Post-
treatment Follow-up 
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Procedures 
Participants were recruited from a number of physical and online locations. 
Online recruitment consisted of a listing on the Trichotillomania Learning Center (TLC) 
“Find a Treatment Provider” page. Fliers were placed on multiple university campuses 
and were emailed to university mental health providers throughout Utah (see Appendix 
A). Participants responded to the recruitment flyers by phone or email. An initial 
screening (see Appendix B) by telephone assessed for general trichotillomania 
symptomology and gave the participant an opportunity to inquire about the study. If the 
participant appeared to meet the study criteria and showed interest in the study, an intake 
session was scheduled. Additionally, instructions on how to set up their computer to 
allow for telepsychology services were emailed to the participant at this time. Support by 
phone was also available. 
Intake sessions took place over the internet using video conferencing software. 
The session took approximately one hour and consisted of receiving informed consent 
(see Appendix C), gathering an electronic signature, and conducting a semi-structured 
interview that assisted in assessing for eligibility in the study. To better determine 
eligibility, each participant also completed a pretreatment assessment battery (see 
Appendix D) consisting of: (a) background information; (b) Massachusetts General 
Hospital Hair Pulling Scale (MGH-HPS); (c) Milwaukee Inventory for Subtypes of 
Trichotillomania-Adult Version (MIST-A); (d) Quality of Life Scale (QOLS); (e) 
Acceptance and Action Questionnaire for Trichotillomania (AAQ-TTM); (f) Valuing 
Questionnaire (VQ); and (g) Experience of Shame Scale (ESS). These assessments (save 
the background information) were again administered at post-waitlist (if applicable), mid-
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treatment, post-treatment, and follow-up to assess the effect of treatment over time. 
Additionally, the Working Alliance Inventory–Short Revised (WAI-SR) was given at 
mid-treatment, post-treatment, and follow-up and the Client Satisfaction Questionnaire–8 
(CSQ-8) was given at post-treatment and follow-up to assess for client-therapist alliance 
and treatment satisfaction. 
Telepsychology Procedures  
All treatment sessions, including intake, utilized telepsychology procedures. The 
use of HIPAA approved video conferencing software (i.e., VSee) allowed for the 
treatment of individuals across the state of Utah who may not have had access to quality 
help for trichotillomania. The video conferencing software allowed the therapist and 
client to see and hear one another throughout each session. The use of telepsychology 
comes with unique risks to confidentiality compared to more traditional psychotherapy. 
For example, clients hold some responsibility for maintaining their confidentiality and 
must ensure that they are in a private location during sessions. Additionally, because no 
therapist communication is face-to-face, it is important to inform clients of security risks 
of phone, email, and video communication. These risks were reviewed with each 
participant at the beginning of the intake session and throughout treatment as necessary. 
Therapists were located in a private, secure location in the Center for Clinical Research at 
Utah State University. All recorded sessions were saved to a HIPAA compliant server 
using Box. All assessments were completed using online survey software (i.e., Qualtrics). 
Furthermore, all participants completed short daily check-ins that briefly assessed hair 
pulling, urges, type of hair pulling, level of willingness to have urges, and level of valued 
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action. These assessments were completed on either the participant’s smartphone or 
computer using a secure online data collection tool (i.e., MetricWire and LifeData).  
Treatment 
 Treatment consisted of a 10-session protocol (see Appendix E) that took place 
over 10 individual weekly one-hour sessions. Of the participants who completed all 10 
sessions, the average treatment length was 12.7 weeks; flexibility allowed the treatment 
provider to accommodate for scheduling conflicts or other participant needs. The protocol 
closely followed an empirically supported ACT-Enhanced Behavior Therapy treatment 
manual (Woods & Twohig, 2008b). The manual blends traditional behavior therapy 
techniques such as habit reversal training and stimulus control with more contemporary 
behavior therapy elements from ACT that employ techniques to change the function of 
the urges to pull as well as the associated cognitions. 
Measures 
Diagnostic Assessments and Clinical Tools  The following tools were used to gather basic demographic and clinically relevant information and to monitor hair pulling behavior over the course of treatment. 
Background information. This assessment gathered basic information from the 
participant such as, sex, age, race, ethnic identity, marital status, and education. 
Additionally, it assessed factors related to trichotillomania and mental health such as, 
how long participants had been pulling their hair, previous psychological treatment, other 
mental health diagnoses, and use of psychotropic medication. 
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The Miniature International Neuropsychiatric Interview (MINI; Sheehan et 
al., 1998). The MINI is a short, structured diagnostic interview assessing for Axis I 
symptoms as outlined by the Diagnostic and Statistical Manual of Mental Disorders–
Fourth Edition (DSM-IV; American Psychiatric Association, 2000). It has been validated 
in numerous studies and is considered to be a more time-efficient alternative to longer 
structured measures (Sheehan et al., 1998). It was used in the current study to ensure 
participant eligibility by screening for comorbid disorders that might be of greater 
concern than trichotillomania.  
The Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version 
(MIST-A; Flessner et al., 2008c). The MIST-A is a 15-item self-report measure 
consisting of two subscales that assesses for the type of hair pulling. Individual items are 
rated on a nine-point Likert-type scale (1 = Not true for any of my hair-pulling to 9 = 
True for all of my hair-pulling). The Focused Pulling Scale consists of 10 items that 
assess symptoms related to focused hair pulling (e.g., “I intentionally start to pull my 
hair”). The scale items are summed and scores range from 10 – 90 with higher scores 
indicating more focused hair pulling. The Automatic Pulling Scale consists of 5 items 
that assess symptoms related to automatic pulling (e.g., “I don’t notice that I have pulled 
my hair until after it’s happened”). The scale items are summed and scores range from 5 
to 45 with higher scores indicating more automatic pulling. Based on a normative sample, 
the mean score of the Focused Pulling Scale was 45.5, SD = 16.2 while the Automatic 
Pulling Scale was 25.7, SD = 9.04 (Flessner, Woods, Franklin, Cashin, & Keuthen, 
2008). Both subscales of the MIST-A have demonstrated adequate internal consistency 
(focused α = .77, automatic α = .73) and good convergent and divergent validity (Flessner 
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et al., 2008c). The MIST demonstrated acceptable internal consistency in the current 
study (Automatic α = .74; Focused α = .78). 
Daily assessment. Participants were asked to fill out basic self-monitoring 
questions each day, these included: (a) How many hairs did you pull today?; (b) How 
many minutes did you spend pulling today?; (c) How many urges to pull did you 
experience today?; (d) How strong were the urges to pull today? (on average); (e) How 
much of your pulling today was automatic or focused?; (f) Rate your level of willingness 
today (on average); (g) How successful were you today at engaging in actions that are in 
line with your values? (on average). These data were collected using secure online data 
collection tools (i.e., MetricWire and LifeData). Participants were prompted to check in 
daily to record their data. The participants and therapist monitored and discussed the 
participant’s progress using a summary spreadsheet during each therapy session. 
Additionally, these data collection tools were used for homework between sessions. For 
example, participants were asked to complete urge monitoring assessments following 
urges to pull. The participant would use these tools to answer questions related to the 
urge they had just experienced (e.g., “what thoughts, emotions, or sensations did you 
notice?” or “Did you use any control strategies in an attempt to reduce or remove the 
urge?”). 
Primary Outcome Measures 
The following assessments were used to measure primary dependent variables of 
interest at each time point. 
Massachusetts General Hospital Hair Pulling Scale (MGH-HPS; Keuthen, 
O'Sullivan, Ricciardi, & Shera, 1995a). The MGH-HPS is a seven-item self-report 
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measure that assesses urges to pull hair, actual pulling behavior, and the distress caused 
from pulling. Individual items are rated from 0 to 4 and are then summed into a 0 to 28 
point total score, with higher scores indicating a higher degree of hair pulling severity. 
Score reductions of seven points or more are considered to be indicative of clinically 
significant treatment response and disorder remission (Houghton et al., 2015). The MGH-
HPS displays good internal consistency (α = .89; Keuthen et al., 1995a), test-retest 
reliability (r = .97), and convergent and divergent validity (O'Sullivan et al., 1995). The 
MGH-HPS demonstrated acceptable internal consistency in the current sample (α = .75). 
Quality of Life Scale (QOLS; Burckhardt, Woods, Schultz, & Ziebarth, 1989). 
The QOLS is a 16-item self-report scale that measures several aspects of functional status 
including, relationships, employment, health, and recreation. Items are rated on a seven-
point Likert-type scale that asks how satisfied the respondent is in these areas (1 = 
terrible to 7 = delighted). Scores are then summed into a 16 to 112 point total score, with 
higher scores indicating greater quality of life. The average total score for healthy 
populations is approximately 90 (Burckhardt & Anderson, 2003). Score increases of 
seven to eight points generally indicate clinically significant improvement (Burckhardt & 
Anderson, 2003). The QOLS has demonstrated good internal consistency (α = .82 to .92) 
and test-retest reliability (r = .78 to .84; Burckhardt & Anderson, 2003), as well as good 
convergent and divergent validity (Burckhardt, Anderson, Archenholtz, & Hägg, 2003). 
The QOLS demonstrated good internal consistency in the current sample (α = .86). 
Secondary Process of Change Measures 
The following assessments were used to measure potential changes in processes 
hypothesized to be related to treatment outcome at each time point. 
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Acceptance and Action Questionnaire for Trichotillomania (AAQ-TTM; 
Houghton et al., 2014). The AAQ-TTM is a nine-item self-report measure of 
psychological inflexibility, specifically designed for trichotillomania populations. The 
measure consists of two factors: interference, which relates to the relationship between 
general functioning and urges to pull, and control, which relates to the management of 
and attitudes toward urges to pull. Items are rated on a seven-point Likert-type scale (1 = 
never true to 7 = always true) that are then summed into a 7 to 63 point total score, with 
higher scores indicating greater levels of psychological inflexibility. Higher levels of 
psychological inflexibility have been shown to be related to a wide variety of conditions, 
including, depression, anxiety, and overall psychological distress. The AAQ-TTM has 
demonstrated good internal consistency (α = .84; Houghton et al., 2014). It also 
demonstrated good convergent and divergent validity as well as incremental validity over 
the Acceptance and Action Questionnaire-II (Bond et al., 2011) from which it is based. 
The AAQ-TTM demonstrated questionable internal consistency in the current sample (α 
= .64); it is worth noting this improved to .85 at posttreatment. 
Experience of Shame Scale (ESS; Andrews, Qian, & Valentine, 2002). The ESS 
is a 25-item measure of shame. It consists of three subscales: (a) characterological shame 
(i.e., personal habits, manner with others, personal ability); (b) behavioral shame (i.e., 
doing something wrong, saying something stupid, failure in competitive situations); and 
(c) bodily shame (i.e., feeling ashamed of any part of your body). Past and current 
experiences, cognitions, and behaviors related to shame are measured on a four-point 
Likert-type scale (1 = Not at all to 4 = Very much) that are then summed into a 25 to 100 
point total score. The original validation study that included 163 undergraduate university 
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students found mean scores of 55.58 (13.95), 24.43 (7.25), 21.25 (5.5), and 9.82 (3.40) 
for the total, characterological, behavioral, and bodily scales, respectively. The ESS has 
demonstrated excellent internal consistency (α = .92) and test retest reliability (r = .83) as 
well as convergent and divergent validity (Andrews et al., 2002). The ESS demonstrated 
excellent internal consistency in the current sample (α = .95). 
Valuing Questionnaire (VQ; Smout, Davies, Burns, & Christie, 2014). The VQ 
is a 10-item self-report measure of engagement in valued living. It consists of two 
factors: progress, which measures awareness and engagement with what is personally 
important, and obstruction, which measures disruptions in valued living due to avoidance 
or distraction. Items are rated on a seven-point Likert-type scale (0 = Not at all true to 6 = 
Completely true) which are then summed into progress and obstruction total scores (five 
items each). Due to an error in the development of the assessment battery, item 5 (“I 
made progress in the areas of my life I care most about”) was not included in the current 
study. Thus, the progress subscale only includes four of the intended five items. The VQ 
has demonstrated good internal consistency (α = .87) as well as convergent and divergent 
validity (Smout et al., 2014). The obstruction subscale demonstrated good internal 
consistency in the current sample (α = .84) and the four-item progress subscale 
demonstrated acceptable internal consistency (α = .76). 
Treatment Acceptability Measures 
The following assessments were used to measure client-rated therapeutic alliance 
at mid- and post-treatment and overall treatment satisfaction at mid- and post-treatment 
and follow-up. 
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Working Alliance Inventory – Short Revised (WAI-SR; Hatcher & Gillaspy, 
2006). The WAI-SR is a 12-item self-report measure of perceived therapeutic alliance. 
The measure consists of three factors: (a) goal agreement, agreement between the 
therapist and client regarding the goals of treatment; (b) task agreement, agreement on 
how to achieve these goals; (c) and bond, the relationship and alliance between the 
therapist and client. Items are rated on a five-point Likert-type scale (1 = seldom to 5 = 
always) that are then averaged into a 1 to 5 point total score, with higher scores indicating 
greater levels of therapeutic alliance. The WAI-SR has demonstrated good test-retest 
reliability (r = .85–.93) and convergent and divergent validity (Hatcher & Gillaspy, 
2006). The WAI-SR demonstrated excellent internal consistency in the current sample (α 
= .98). 
Client Satisfaction Questionnaire–8 (CSQ-8; Attkisson & Zwick, 1982). The 
CSQ-8 is an eight-item version of the original Client Satisfaction Questionnaire (Larsen, 
Attkisson, Hargreaves, & Nguyen, 1979). It is a single factor self-report measure of client 
satisfaction of treatment. Items are rated on a four-point Likert-type scale where 1 
indicates a low degree of satisfaction and 4 indicates high satisfaction. Scores are 
summed into an 8 to 32 point total score with high scores indicating greater levels of 
treatment satisfaction. The CSQ-8 has demonstrated good internal consistency (α 
= .84–.93) as well as convergent and divergent validity. The CSQ-8 demonstrated 
excellent internal consistency in the current sample (α = .98).   
Data Analytic Strategy 
 Data was collected using online survey software (i.e., Qualtrics). All participants 
received a research identification number, which was used to collect anonymous data 
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online. All collected data was analyzed using R statistical software (R Development Core 
Team, 2016) and the following packages: car (Fox & Weisberg, 2011), lme4 (Bates, 
Maechler, Bolker, & Walker, 2015), psy (Falissard, 2012), psych (Revelle, 2017), 
tidyverse (Wickham, 2017), and jmv (Selker, Love, & Dropmann, 2017). An intent-to-
treat approach was taken for all analyses such that all collected data were used, including 
dropouts. 
 Descriptive statistics, including demographic information and means for each of 
the measures at the various treatment stages were calculated for both the experimental 
and control groups. Comparisons were then made between the groups, using Welche’s t-
tests and Pearson’s chi-squared tests to ensure that groups were similar at the beginning 
of the study with regard to demographic, dependent, and independent variables. Internal 
consistency of each of the identified measures was computed to establish scale reliability. 
Primary Analysis 
The primary outcomes of interest were the severity of trichotillomania symptoms 
(as measured by the MGH-HPS) and quality of life (as measured by the QOLS). 
ANCOVAs were used to assess the effect of the treatment condition on post-treatment 
trichotillomania symptom severity and quality of life after controlling for pre-treatment 
levels compared to the waitlist condition. Post-treatment scores were entered as a 
dependent variable, treatment condition was entered as an independent variable, and pre-
treatment scores were entered as a covariate. Effect sizes are reported using ω², as it 
produces less biased and more conservative effect sizes compared to η², especially in 
small samples (Albers & Lakens, 2017). ω² can be interpreted using the same rough 
criteria as η² (i.e., small = 0.01, medium = 0.06, large = 0.14). Post hoc analyses were 
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performed with a Bonferroni adjustment. Because both conditions eventually received 
treatment, data from all participants was then combined. Mixed model repeated measures 
analyses were used to assess outcome across pre-treatment, mid-point, post-treatment, 
and three-month follow-up. This method allows all available data to be used to model 
change over time, while modeling any missing data. Participants were specified in the 
model as a random factor to control for interclass correlations and time was specified as a 
fixed factor. Using chi-square tests on the log-likelihood values, this model was 
compared to an intercept only model (excluding the time variable) and a model that 
allowed for slopes to vary by participant. The model-fit was significantly better than the 
intercept only model (ps < .01 and was not significantly improved by adding random 
slopes (ps > .10) for all variables. Therefore, the original random intercept, fixed slopes 
model was retained and utilized in all mixed model analyses. 
Secondary Analysis 
Similar analytic procedures were conducted using the AAQ-TTM, VQ, and ESS 
to determine differences between the experimental and control groups with regard to 
psychological flexibility, engagement in valued living, and levels of shame. As before, 
the data were combined and these measures were examined across pre-treatment, mid-
point, post-treatment, and follow-up using mixed model repeated measures analyses. 
Finally, mean scores for the WAI-SR and CSQ-8 were examined to assess perceived 
alliance with therapist and satisfaction with treatment. 
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CHAPTER IV 
RESULTS 
 
Treatment Adherence 
 The author conducted the treatment for 15 participants. The remaining seven 
participants received treatment from a single graduate assistant therapist. Both therapists 
involved in the study were supervised by a licensed psychologist who co-authored the 
treatment manual that the study treatment protocol was based on. All sessions were video 
and audio recorded using the built-in recording function in VSee. Twenty percent of all 
sessions were viewed and scored for the quantity and quality of the coverage of each 
treatment component using a standardized treatment integrity scoring system used in 
previous ACT research (Crosby & Twohig, 2016; Twohig & Crosby, 2010a). Two 
sessions from each 10-session treatment were systematically chosen such that each 
session number was reviewed approximately five times. A graduate assistant reviewer 
who did not provide treatment scored each of the 48 selected sessions. This reviewer had 
received coding training for a previous project and scored reliably (above .90) with the 
author in the previous project. The reviewer also scored reliably with the author on five 
of the sessions from the current study that were conducted by the graduate assistant 
therapist. 
 For every coded session, HRT consistent (i.e., awareness training, competing 
response training, and contingency management), ACT consistent (i.e., acceptance, 
defusion, self as context, present moment awareness, values clarification, and committed 
action), and ACT inconsistent (i.e., cognitive challenging, experiential avoidant change 
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strategies, and thoughts and feelings cause action) behaviors were rated on a five-point 
Likert-type scale (1 = the variable was never explicitly covered to 5 = the variable 
occurred with high frequency and was covered in a very in-depth manner) Additionally, 
therapist adherence to the treatment model and therapist competency were rated on the 
same scale. The average score for each HRT process over the 10 sessions are as follows: 
awareness training (M = 2.10, SD = 1.07), competing response training (M = 1.90, SD = 
1.09), and contingency management (M = 1.76, SD = 1.30). The average score for each 
ACT process are as follows: acceptance (M = 2.98, SD = 1.25), defusion (M = 2.49, SD = 
1.38), contact with the present moment (M = 1.98, SD = 1.08), self as context (M = 1.27, 
SD = 0.74), values (M = 1.95, SD = 1.22), and committed action (M = 2.78, SD = 0.76). 
Of note, each process was rated “5” for at least one session, indicating that each process 
was covered in an in-depth manner. Moreover, therapist adherence to the treatment model 
and therapist competency were rated highly (M = 4.00, SD = 0.67) and (M = 4.20, SD = 
0.51), respectively. Finally, all ACT inconsistent processes were rated “1” for every 
session, indicating that they were not present. 
Examination of Data 
Boxplots for each outcome and process variable were examined at each time point 
in order to detect potential outliers. No outliers (as defined by greater than 3 box lengths 
from the mean) were found. However, eight potential outliers (as defined by greater than 
1.5 box lengths from the mean) were found. These included one high and one low MGH-
HPS score and two low VQ progress scores at pre-treatment, one low VQ progress score 
at post-waitlist, one low VQ progress score at mid-treatment, one low VQ progress score 
at post-treatment, and one high MGH-HPS score at follow-up. Each of these scores were 
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examined and not deemed unusual for the given measure or sample and therefore retained 
for all analyses. 
All variables included in analyses were examined to assess for assumptions of 
normality. All were normally distributed as assessed by the Shapiro-Wilk test (ps >.05) 
and Normal Q-Q Plots. Additionally, there was homogeneity of variances as assessed by 
Levene's test (ps >.05). 
Differences Between Conditions 
Comparisons between the treatment and waitlist group were made for each 
demographic, dependent, and independent variable to examine potential differences 
between the groups. Welche’s t-tests were used for continuous data and Pearson’s chi-
squared tests were used for categorical data. No significant differences between treatment 
and waitlist conditions were found for any variables at intake (ps > .05), thus indicating 
that the groups were similar upon entering the study. See Table 3 for complete 
comparison data. 
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Table 3 
Descriptive Statistics with Welche’s t-Test or Pearson’s Chi Squared Comparisons Between Groups 
 Treatment (n = 12) Waitlist (n = 10)   
Variable n % M SD n % M SD t / X2 p 
Age   34.2 9.4   30.4 6.8 1.09 .29 
Sex         .03 .87 
       Male 1 8.3   2 20.0     
       Female 11 91.7   8 80.0     
Sexual orientation         4.75 .19 
       Heterosexual 11 91.7   7 70.0     
       Gay or lesbian - -   2 20.0     
       Bisexual - -   1 10.0     
       Other 1 8.3   - -     
Race/ethnicity         .01 .93 
       White 12 100   9 90.0     
       Asian - -   1 10.0     
       Hispanic or Latinx 1 8.3   - -     
Education         2.99 .39 
       High school 3 25.0   - -     
       Some college 3 25.0   4 40.0     
       Bachelor’s degree 3 25.0   3 30.0     
       Graduate degree 3 25.0   3 30.0     
Marital status         .03 .87 
       Single 2 16.7   4 40.0     
       Married 8 66.7   5 50.0     
       Divorced 1 8.3   1 10.0     
       Remarried 1 8.3   - -     
Monthly income         3.04 .22 
       $1,000 to $2,999 3 25.0   6 60.0     
       $3,000 to $7,999 6 50.0   2 20.0     
       More than $7,999 3 25.0   2 20.0     
MGH-HPS   15.6 5.2   14.9 3.0 .38 .71 
QOLS   80.0 13.3   81.6 12.2 .29 .77 
MIST-A automatic   26.0 10.4   30.4 6.3 1.18 .25 
MIST-A focused   34.3 11.6   36.4 20.7 .28 .78 
AAQ-TTM   40.2 8.2   41.3 8.2 .32 .75 
ESS total   59.4 19.0   61.1 14.1 .24 .81 
ESS character   27.8 10.8   28.8 6.5 .26 .80 
ESS behavior   19.7 6.5   22.9 7.5 1.04 .31 
ESS body   10.7 3.0   9.4 2.5 1.10 .29 
VQ obstruction   12.8 7.2   13.7 6.9 .29 .78 
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VQ progressa   15.4 4.1   17.5 5.0 1.06 .30 
Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = Experience of 
Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; MIST-A = Milwaukee 
Inventory for Styles of Trichotillomania – Adult Version; QOLS = Quality of Life Scale; VQ = Valuing 
Questionnaire. 
aSubscale missing item 5. 
 
 
Condition Comparison Summary 
 Table 4 summarizes outcome variable means and standard deviations for the 
treatment and waitlist groups at time 1 (pre-treatment and pre-waitlist) and time 2 (post-
treatment and post-waitlist). In addition, Figure 2 displays these data as line graphs. 
ANCOVAs were used to evaluate differences between the treatment and waitlist 
condition for each variable of interest at post-treatment, controlling for pre-treatment 
levels. 
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Table 4 
Outcome Means and Standard Deviations at Times 1 and 2 By Condition 
 Time 1 Time 2 
 Treatment  
(n = 12) 
Waitlist  
(n = 10) 
Treatment  
(n = 11) 
Waitlist  
(n = 9) 
Variable M SD M SD M SD M SD 
MGH-HPS 15.58 5.21 14.90 3.00 9.00 4.52 18.10 5.00 
QOLS 80.00 13.25 81.60 12.21 86.91 15.10 79.70 12.65 
MIST-A automatic 26.00 10.45 30.40 6.26 25.91 10.57 29.80 8.78 
MIST-A focused 34.33 11.59 36.40 20.68 35.50 12.79 42.20 18.75 
AAQ-TTM 40.17 8.16 41.30 8.21 32.30 10.86 39.90 10.90 
ESS total 59.36 18.98 61.10 14.09 54.45 19.69 64.70 17.52 
ESS character 27.83 10.79 28.80 6.51 25.73 11.12 31.60 9.74 
ESS behavior 19.73 6.47 22.90 7.48 18.36 6.59 23.30 6.57 
ESS body 10.67 2.96 9.40 2.46 10.36 4.08 9.80 3.36 
VQ obstruction 12.83 7.21 13.70 6.93 11.00 6.72 15.00 6.93 
VQ progressa 15.42 4.08 17.50 4.97 17.50 3.24 13.20 5.59 
Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = 
Experience of Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; 
MIST-A = Milwaukee Inventory for Styles of Trichotillomania – Adult Version; QOLS = 
Quality of Life Scale; VQ = Valuing Questionnaire. 
aSubscale missing item 5. 
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Figure 2. Line graphs of variables of interest from Time 1 to Time 2 by group 
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Effects on Hair Pulling Severity 
After adjusting for pre-treatment MGH-HPS scores, there was a statistically 
significant difference in post-treatment scores between conditions, F(1, 18) = 19.627, p 
< .001, ω² = .473. MGH-HPS scores were statistically significantly greater in the waitlist 
condition (18.10 ± 4.52) compared to the treatment condition (9.00 ± 5.00), a mean 
difference of 9.32 (p < .001). The treatment group displayed a 42.2% decrease in MGH-
HPS scores, while the waitlist group displayed a 17.7% increase from time 1 to time 2. 
Seven of the 12 (58.3%) treatment completers saw MGH-HPS score reductions of seven 
points or greater, indicating clinically significant improvement. These findings indicate 
that, on average, treatment had a significant, large effect on hair pulling severity. 
Effects on Quality of Life 
After adjusting for pre-treatment QOLS scores, there was no statistically 
significant difference in post-treatment scores between conditions, F(1, 18) = 1.910, p 
= .183, ω² = .032. On average, the treatment groups displayed an 8.0% increase in 
QOLS scores, indicating a slight improvement in quality of life from pre- to post-
treatment. This improvement was a nonsignificant change compared to the waitlist 
group. 
Effects on Psychological Flexibility 
 After adjusting for pre-treatment AAQ-TTM scores, there was no statistically 
significant difference in post-treatment scores between conditions, F(1, 18) = 3.790, p 
= .068, ω² = .064. On average, the treatment groups displayed a 19.6% decrease in AAQ-
TTM scores, indicating improved trichotillomania-related psychological flexibility from 
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pre- to post-treatment. This improvement was a nonsignificant change compared to the 
waitlist group which displayed a 3.4% decrease in scores. 
Effects on Shame 
 Total scores. After adjusting for pre-treatment ESS total scores, there was no 
statistically significant difference in post-treatment scores between conditions, F(1, 18) = 
3.360, p = .084, ω² = .032. On average, the treatment groups displayed an 8.3% decrease 
in ESS total scores, indicating a slight improvement in overall experienced shame from 
pre- to post-treatment. This improvement was a nonsignificant change compared to the 
waitlist group which displayed a 5.6% increase in scores. 
 Character-related shame. After adjusting for pre-treatment ESS character 
scores, there was no statistically significant difference in post-treatment scores between 
conditions, F(1, 18) = 4.06, p = .059, ω² = .050. On average, the treatment groups 
displayed a 7.6% decrease in ESS character scores, indicating a slight improvement in 
character-related experienced shame from pre- to post-treatment. This improvement was 
a nonsignificant change compared to the waitlist group which displayed an 8.9% increase 
in scores. 
Behavior-related shame. After adjusting for pre-treatment ESS behavior scores, 
there was no statistically significant difference in post-treatment scores between 
conditions, F(1, 18) = 2.68, p = .120, ω² = .021. On average, the treatment groups 
displayed a 6.6% decrease in ESS character scores, indicating a slight improvement in 
behavior-related experienced shame from pre- to post-treatment. This improvement was a 
nonsignificant change compared to the waitlist group which displayed an 1.7% increase 
in scores. 
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Body-related shame. After adjusting for pre-treatment ESS body scores, there 
was no statistically significant difference in post-treatment scores between conditions, 
F(1, 18) = 4.83, p = .338, ω² = .001. On average, the treatment and waitlist groups 
displayed no meaningful change on body-related shame from time 1 to time 2. 
Effects on Values 
 Obstruction. After adjusting for pre-treatment VQ obstruction scores, there was a 
statistically significant difference in post-treatment scores between conditions, F(1, 18) = 
5.05, p = .037, ω² = .062. VQ obstruction scores were statistically significantly greater in 
the waitlist condition (15.00 ± 6.93) compared to the treatment condition (11.00 ± 6.72), 
a mean difference of 3.80 (p = .037). On average, the treatment groups displayed a 14.3% 
decrease in VQ obstruction scores, indicating a decrease in behaviors that hinder valued 
living from pre- to post-treatment. This improvement was a significant change compared 
to the waitlist group which displayed an 8.7% increase in scores. 
Progress. After adjusting for pre-treatment VQ progress scores, there was a 
statistically significant difference in post-treatment scores between conditions, F(1, 18) 
= 20.900, p < .001, ω² = .295. VQ obstruction scores were statistically significantly 
greater in the waitlist condition (17.50 ± 3.24) compared to the treatment condition 
(13.20 ± 5.59), a mean difference of 6.06 (p < .001). On average, the treatment groups 
displayed a 11.9% increase in VQ progress scores, indicating increased movement 
toward values from pre- to post-treatment. This improvement was a nonsignificant 
change compared to the waitlist group which displayed a 24.6% decrease in scores. 
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Combined Follow-up Analysis 
 The treatment and waitlist group treatment data were combined and examined 
using mixed model repeated measures analyses across four time-points (i.e., pre-
treatment, mid-treatment, post-treatment, and 3-month follow-up). See table 5 for a 
summary of outcome variable means and standard deviations at each time point, Table 6 
for results of the mixed models repeated measures analyses, and Figure 3 for line graphs 
visualizing the same data. 
Effects on Hair Pulling Severity 
Significant improvements on MGH-HPS scores were observed from pre- to post-
treatment, slope estimate = -6.13, SE = 1.30, t(58.48) = -4.72, p < .001. On average, 
scores decreased 39.4% from pre- post-treatment with 12 (60.0%) participants 
demonstrating reductions of seven points or greater, indicating clinically significant 
reductions in hair pulling severity. This percentage decreased to 26.3% at follow-up with 
seven (36.8%) maintaining clinically significant score reductions three months following 
treatment. On average, the score increases from post-treatment to follow-up were 
nonsignificant, slope estimate = -1.95, SE = 1.34, t(57.19) = 1.45, p = .152. 
Effects on Quality of Life 
 QOLS scores did not significantly change from pre- to post-treatment, slope 
estimate = 5.58, SE = 3.36, t(57.92) = 1.66, p = .103. On average, scores increased 6.9% 
from pre- to post-treatment with 11 (55.0%) participants demonstrating increases of 
seven points or greater, indicating clinically significant increases in quality of life. This 
percentage decreased to 3.4% at follow-up, with seven (36.8%) participants 
demonstrating clinically significant score increases three months following treatment. On 
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average, the score decreases from post-treatment to follow-up were nonsignificant, slope 
estimate = 3.20, SE = 3.45, t(56.48) = 0.93, p = .358. 
Effects on Psychological Flexibility 
 Significant improvements on AAQ-TTM scores were observed from pre- to post-
treatment, slope estimate = -11.78, SE = 2.01, t(55.85) = -5.85, p < .001. On average, 
scores decreased 28.1% from pre- to post-treatment and remained relatively stable 
through follow-up with a 26.5% decrease from pre-treatment to follow-up. On average, 
the score increases from post-treatment to follow-up were nonsignificant, slope estimate 
= 1.01, SE = 2.06, t(54.58) = 0.49, p = .627. 
Effects on Shame 
 ESS total scores decreased nonsignificantly from pre- to post-treatment, slope 
estimate = -2.54, SE = 2.54, t(56.37) = -1.00, p = .321. Scores decreased only 3.1% from 
pre- to post-treatment. However, at follow-up this change was 18.2% from pre-treatment. 
On average, participants demonstrated a significant decrease in scores from post-
treatment to follow-up, slope estimate = -8.50, SE = 2.55, t(55.17) = -3.33, p = .002. This 
pattern was consistent for the character (3.6% and 19.8% decreases), behavior (3.2% and 
17.8% decreases), and body (3.9% increase and 9.7% decrease) subscales. In addition, 
the total and subscale scores each began above or similar to the norms from the original 
validation study (+4.61, +3.84, -0.01, +0.27, respectively) and decreased below them at 
follow-up (-6.32, -1.75, -3.78, -0.71, respectively), indicating meaningful changes in 
shame from pre-treatment to follow-up. 
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Effects on Values 
 Obstruction. Significant improvements on VQ obstruction scores were observed 
from pre- to post-treatment, slope estimate = -3.52, SE = 1.42, t(57.06) = -2.47, p = .016. 
On average, the score increases from post-treatment to follow-up were nonsignificant, 
slope estimate = -1.01, SE = 1.46, t(55.60) = -0.69, p = .493. However, overall 
improvements from pre-treatment to follow-up were significant, slope estimate = 4.53, 
SE = 1.45, t(57.27) = 3.13, p = .003. Scores decreased 23.7% from pre- to post-treatment 
and 33.6% from pre-treatment to follow-up. 
Progress. VQ progress score improvements from pre- to post-treatment were 
nonsignificant, slope estimate = 1.35, SE = .94, t(57.12) = 1.44, p = .154. Improvements 
from post-treatment to follow-up were also nonsignificant, slope estimate = .44, SE 
= .96, t(55.76) = .46, p = .648. Scores increased 7.2% from pre- to post-treatment and 
12.8% from pre-treatment to follow-up. 
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Table 5 
Combined Outcome Means and Standard Deviations at Pre-, Mid-, and Post-Treatment and 3 Month 
Follow-Up 
 Pre-treatment  
(n = 22) 
Mid-treatment  
(n = 20) 
Post-treatment  
(n = 20) 
Follow-up  
(n = 19) 
Variable M SD M SD M SD M SD 
MGH-HPS 15.27 4.27 10.20 4.16 9.25 4.24 11.26 5.97 
QOLS 80.73 12.51 85.50 12.94 86.70 16.47 83.71 19.06 
MIST-A 
automatic 
28.10 8.79 28.65 8.31 26.20 10.68 23.58 9.60 
MIST-A focused 35.27 15.96 41.45 15.13 39.47 17.29 31.89 18.64 
AAQ-TTM 40.68 8.00 35.37 10.96 29.26 11.17 29.89 8.77 
ESS total 60.19 16.44 61.10 13.85 58.30 17.73 49.26 11.96 
ESS character 28.27 8.91 28.70 7.87 27.25 10.13 22.68 6.16 
ESS behavior 21.24 5.98 21.95 5.65 20.55 6.71 17.47 5.38 
ESS body 10.09 2.76 10.45 3.09 10.50 3.66 9.11 3.23 
VQ obstruction 13.23 6.93 11.26 5.34 10.10 6.32 8.79 5.07 
VQ progressa 16.36 4.52 17.60 3.38 17.63 4.81 18.26 3.89 
Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = Experience of 
Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling Scale; MIST-A = Milwaukee 
Inventory for Styles of Trichotillomania – Adult Version; QOLS = Quality of Life Scale; VQ = 
Valuing Questionnaire. 
aSubscale missing item 5. 
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Figure 3. Line graphs of variables of interest from pre-treatment to follow-up. 
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Table 6 
Mixed Models Repeated Measures Results for Changes Within Treatment 
 Slope Estimate 
Standard 
Error df t-value p 
MGH-HPS       
      Pre to Mid -5.18 1.30 58.48 -3.99 < .001 
      Pre to Post -6.13 1.30 58.48 -4.72 < .001 
      Pre to Follow-up -4.18 1.32 58.92 -3.17 .002 
      Post to Follow-up 1.95 1.34 57.19 1.45 .152 
QOLS      
      Pre to Mid 4.37 3.31 57.90 1.32 .192 
      Pre to Post 5.57 3.31 57.90 1.68 .098 
      Pre to Follow-up 2.48 3.37 58.06 0.74 .465 
      Post to Follow-up 3.09 3.40 56.46 0.91 .366 
AAQ-TTM      
      Pre to Mid -5.33 2.01 55.85 -2.65 .010 
      Pre to Post -11.78 2.01 55.85 -5.85 < .001 
      Pre to Follow-up -10.77 2.01 55.85 -5.35 < .001 
      Post to Follow-up 1.01 2.06 54.48 0.49 .627 
ESS total      
      Pre to Mid 0.26 2.54 56.37 0.10 .919 
      Pre to Post -2.54 2.54 56.37 -1.00 .321 
      Pre to Follow-up -11.04 2.58 56.44 -4.27 < .001 
      Post to Follow-up -8.50 2.55 55.17 -3.33 .002 
VQ obstruction      
      Pre to Mid -2.05 1.45 57.27 -1.42 .162 
      Pre to Post -3.52 1.42 57.06 -2.47 .016 
      Pre to Follow-up -4.53 1.45 57.27 -3.13 .003 
      Post to Follow-up -1.01 1.46 55.60 -0.69 .493 
VQ progress      
      Pre to Mid 1.24 0.92 56.94 1.35 .183 
      Pre to Post 1.35 0.94 57.12 1.44 .154 
      Pre to Follow-up 1.79 0.94 57.12 1.91 .061 
      Post to Follow-up 0.44 0.96 55.76 0.46 .648 
Note. AAQ-TTM = Acceptance and Action Questionnaire for Trichotillomania; ESS = 
Experience of Shame Scale; MGH-HPS = Massachusetts General Hospital Hair Pulling 
Scale; QOLS = Quality of Life Scale; VQ = Valuing Questionnaire. 
 
 
Telehealth Factors 
At intake, participants were asked questions related to their reasons for seeking 
treatment and whether the telehealth aspect of the treatment interested them. See Table 6 
for a summary. Forty percent of the participants reported that they would not have been 
seeking treatment if it were not provided over the internet. Moreover, 59.1% said that 
they were unable to find treatment for trichotillomania where they lived. Thus, telehealth 
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was the only feasible treatment option for over half of the participants. Additionally, half 
of the participants reported that their busy schedule inhibited them from seeking face-to-
face therapy. Because these individuals signed up for the study, the prospect of telehealth 
may have been more convenient than face-to-face therapy. 
 
Table 7 
Participant Interest in Telehealth Treatment 
  
Variable N / Mean % / SD 
Would you be seeking treatment if it was 
not provided over the internet? 
  
Yes 13 59.9 
No 9 40.1 
What circumstances would inhibit you from 
attending face-to-face therapy? 
  
       Busy schedule 11 50.0 
       Trichotillomania treatment is not 
available near me 
13 59.1 
       Lack of money or resources (e.g., 
travel, bus fair, gas money, child care) 
8 36.4 
 
 
Working Alliance 
Participants were assessed for therapist-client working alliance following session 
five (mid-treatment) and at post-treatment. The majority of participants averaged scores 
of four or greater at post-treatment (goal = 90%, task = 80%, bond = 80%), indicating 
very good levels of perceived therapeutic alliance. See Table 7 for a summary of mean 
scores and standard deviations. Moreover, very few participants had mean scores below 
three, and most were above four. At post-treatment, two participants scored below a three 
on the task subscale, and only one scored below a three on the goal and bond subscales. 
See Figure 4 for box plots and individual participant mean scores. For comparison, the 
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mean WAI-SR scores in the current study were all higher than the mean scores gathered 
in the original development of the measure (Munder, Wilmers, Leonhart, Linster, & 
Barth, 2010). The original mean scores were gathered from 88 outpatients at a university 
clinic (goal = 4.0, task = 3.4, bond = 4.0, total = 3.8). In comparison to these scores, 
participants in the current study reported greater levels of perceived therapeutic alliance. 
The task subscale was slightly lower than other subscales at mid-point (3.90), 
perhaps indicating some therapist-participant disagreement on how to best work toward 
the participant’s goals. The mid-point assessment immediately followed sessions that 
presented acceptance as an alternative to control strategies. This creative hopelessness 
process and identification of control as the problem with acceptance as a new strategy is 
often novel and at times confusing to participants. At this point in treatment, being asked 
to make space for difficult internal events may not seem like a solution to some problems. 
In short, clients may not have fully bought into this approach at this point in treatment. 
Therefore, participants may have scored items such as 12 (“I believe the way we are 
working with my problems is correct.”), lower at this point in treatment. The task 
subscale score notably improved at the post-treatment assessment (4.39), indicating that 
participants felt that, on average, the methods introduced in treatment were largely 
helpful in helping them achieve their goals.  
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Table 8 
Client Satisfaction and Working Alliance Means and Standard Deviations 
 Mid-treatment 
(n = 20) 
Post-treatment 
(n = 20) 
Follow-up 
(n = 19) 
Variable M SD M SD M SD 
CSQ-8 29.20 3.16 29.65 5.48 29.20 3.16 
WAI-SR total 4.36 1.75 4.49 2.62 - - 
WAI-SR goal 4.59 0.51 4.56 0.73 - - 
WAI-SR task 3.90 0.97 4.39 1.06 - - 
WAI-SR bond 4.58 0.52 4.53 0.93 - - 
Note. CSQ-8 = Client Satisfaction Questionnaire–8; WAI-SR = Working Alliance 
Inventory–Short Revised. 
   
   54
 
Figure 4. Boxplots with individual participant data points of client-rated working alliance 
scores at mid- and post-treatment by subscale.  
Treatment Satisfaction 
Participants were assessed for their satisfaction with treatment following session 
five (mid-treatment), at post-treatment, and at follow-up. Overall, scores indicated a high 
level of treatment satisfaction. Moreover, average rating scores were relatively stable 
across each assessment period. See Table 8 for a summary of mean scores and standard 
deviations. No norms exist for the CSQ-8 to compare to the current sample, although an 
original psychometric analysis of the measure reported mean scores of 3.02 (0.57) out of 
4 from a sample of 45 community mental health center patients (Attkisson & Zwick, 
1982). In comparison, mean scores for the current sample were 3.65 (0.40), 3.71 (0.69), 
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and 3.65 (0.48) at mid-treatment, post-treatment, and follow-up, respectively. See Figure 
5 for box plots and individual participant CSQ-8 mean scores.  
 
Figure 5. Boxplots with individual participant data points of client-rated treatment 
satisfaction scores at mid-treatment, post-treatment, and follow-up. 
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CHAPTER V 
DISCUSSION 
 
Primary Outcomes 
 The current study attempted to examine whether ACT-enhanced behavior therapy 
could successfully be delivered by way of telepsychology. The primary measures for 
success were defined as significant reductions in hair pulling severity and significantly 
increased quality of life. On average, participants in the treatment condition reported 
significant, large reductions in hair pulling severity from pre- to post-treatment, 
compared to those in the waitlist condition. However, reported quality of life did not 
improve in the same manner, with only small, nonsignificant increases from pre- to post-
treatment.  
 Once the treatment and waitlist groups were combined and three-month follow-up 
data were examined, the story of these outcomes shifts. As is typical for trichotillomania, 
rates of symptom severity declined on average following treatment. Hair pulling severity 
rates at follow-up were still significantly lower than at the beginning of treatment, but 
they were not as low as they were at post-treatment. Overall, these rates of improvement 
are comparable to other ACT-enhanced behavior therapy trials. For example, one trial 
found 44.8% and 24.0% decreases in MGH-HPS scores post-treatment and follow-up, 
respectively, compared to 39.4% and 26.3% in the current trial (Woods et al., 2006c). 
On average, quality of life did not significantly change over the course of 
treatment. Many participants did see clinically significant rates of improvement in quality 
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of life, however. nearly half (45.0%) did not see this level of improvement at post-
treatment and nearly two thirds (63.2%) did not at follow-up. 
Secondary Outcomes 
 The VQ was the only secondary outcome variable that demonstrated significant 
improvement from pre- to post-treatment compared to the waitlist condition. Participants 
reported statistically significant, medium reductions in behaviors that obstructed valued 
living, such as avoidance of internal experiences and distraction from personal values. 
Moreover, participants reported statistically significant, large improvements in making 
progress toward becoming more aware of personal values and successful engagement in 
valued behavior. When combined into a single treatment group, participants 
demonstrated significant reductions in obstruction from valued living from pre-treatment 
to follow-up, but not in progress toward valued living. 
 On average, participants in the treatment condition did not report improved levels 
of trichotillomania-related psychological flexibility or shame from pre- to post-treatment 
compared to the waitlist condition. However, both saw improvement in the desired 
direction with a medium effect size for psychological flexibility and a small effect size 
for overall shame. Moreover, on average, psychological flexibility and shame saw 
statistically significant improvements from pre-treatment to follow-up. 
 The pattern of improvement for shame is notable in that it remained relatively 
stable from pre- to post-treatment, but saw a delayed statistically significant reduction 
following treatment. This delayed effect could be due to multiple factors. The ESS 
demonstrates high levels of test-retest reliability over an 11-week period (.83), indicating 
that it is measuring a trait-like disposition rather than a transient affective state. 
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Therefore, it might take some time before changes are demonstrated on this scale. 
Experiences of shame may also be ameliorated as values consistent behavior is more 
actively engaged in and as quality of life improves. Finally, increased levels of 
psychological flexibility could also potentially play a role. Andrews et al. (2002) 
hypothesized that shame may be part of a reciprocal interaction between dysfunctional, 
self-critical cognitions and self-evaluations that may amplify feelings of shame. As 
psychological flexibility increases, self-critical thoughts may not be as meaningful and 
result in fewer feelings of shame. Moreover, the experiences of shame themselves might 
have less of an impact as one becomes more skilled at making space for these 
experiences and not over identifying with them. 
 Overall, outcome variables of interest tended to improve from pre- to post-
treatment compared to the waitlist control group. When the groups were then combined, 
the within group effects were magnified such that significant changes in all outcome and 
process variables, save quality of life and progress toward valued living, were 
demonstrated from pre-treatment to follow-up. 
Applied Implications 
 A major purpose of the current study was to examine the feasibility of delivering 
treatment for trichotillomania through telepsychotherapy. Overall, it appears that ACT-
enhanced behavior therapy can be successfully delivered using telepsychology methods. 
Findings from the current study are similar to ACT-enhanced behavior therapy trials 
delivered by way of more traditional face-to-face methods, providing further evidence for 
this treatment package. The findings included significant reductions in hair pulling 
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severity over the course of treatment with similar levels of maintenance at follow-up to 
other trials. 
 In addition, participant ratings of treatment satisfaction and working alliance were 
very high. Intuitively, one might suspect that telepsychology would involve a tradeoff 
between the technology and the therapist-participant relationship that might not favor 
these types of ratings. However, it appears that treatment satisfaction and working 
alliance were at least as high as similar face-to-face trials. 
 In part, the high treatment satisfaction ratings might be related to the unique 
qualities of telepsychology. The convenience of participating in therapy from home 
cannot be overstated. Multiple participants in the study reported being very time-
constrained and appreciated the flexibility of telepsychology. Indeed, half of participants 
reported that their busy schedule inhibited them from attending face-to-face therapy. 
Another factor likely contributing to treatment satisfaction is telepsychology’s ability to 
treat those who would otherwise be unable to find quality treatment. Half of participants 
reported having previously sought treatment for trichotillomania and nearly 60% reported 
that treatment for trichotillomania was not available near where they lived. Finally, 
treatment was provided free of charge for participation in the study, which could have 
contributed to satisfaction with treatment. Overall, it appears that the use of 
telepsychology in the current study led to individuals receiving treatment who otherwise 
would not have due to inconvenience, lack of availability, or lack of resources. 
 Shame is another factor that may have kept people from previously seeking 
treatment and that might have been mitigated by telepsychotherapy. Individuals with 
trichotillomania typically have elevated levels of shame related to their urges and pulling 
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behaviors (Stemberger, Thomas, Mansueto, & Carter, 2000; Weingarden & Renshaw, 
2015) and it appears that shame may be a barrier to treatment for some (Singh, 
Wetterneck, Williams, & Knott, 2016). On average, participants reported that 
trichotillomania had been a problem for over 16 years, yet half had not sought treatment. 
Unfortunately, the current study did not directly assess whether shame was a factor in not 
seeking treatment; however, participants reported high levels of shame, on average, upon 
entering the study. The convenience and discretion that telepsychology offers individuals 
who would perhaps otherwise be unwilling to seek therapy could be an important benefit 
of the method. Future research should examine the role of experiences such as shame, 
guilt, and embarrassment in seeking treatment and whether telepsychology improves 
rates of treatment seeking among these individuals. 
 Among these benefits, telepsychotherapy also introduces some difficulties to 
trichotillomania treatment. Real or perceived technical barriers may be intimidating to 
some as they begin treatment. The current study required participants to independently 
install software on their computer, create an account, and sign in to the video 
conferencing software. Detailed setup instructions were provided to participants and 
phone support was needed in a couple of instances. This process, while not overly 
arduous, could be a barrier for some. Luckily, this was not a barrier to treatment in the 
current study. All participants were able to eventually set up and learn the software. 
Modern methods exist that greatly reduce this technical barrier, although they are 
generally costly and often not suitable for small trials or individual therapists. However, 
this hurdle is sure to be reduced as video conferencing software progresses and telehealth 
popularity increases. 
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 Outside of software setup and use, technical difficulties such as dropped 
connections and lag between the therapist and participant, can hinder treatment. 
Occasionally, the video conferencing software did not function properly or the internet 
connection would be very poor requiring the remainder of the session to be completed 
using the telephone. In total, 11 of the 197 (5.6%) sessions required some use of the 
telephone. Lag or dropped connections were a more common problem, but did not 
severely negatively impact treatment.  
 Finally, working with participants while they are in their homes presents unique 
challenges not present in traditional therapy. Participants have an added responsibility to 
tailor their environment in a way that promotes quality treatment and confidentiality. 
Participants can easily become distracted with personal items, notifications on their 
computer or phone, or even children, partners, or friends in their home. Moreover, the 
home environment promotes a casual atmosphere that can perhaps affect treatment. These 
concerns were addressed in the first session with additional reminders as needed 
throughout treatment.  
 Despite the difficulties inherent in telepsychology, treatment was largely 
successful. The format presents unique difficulties, but also distinct benefits not found in 
traditional face-to-face treatment. Participants reported high levels of satisfaction with 
treatment and perceived therapist-participant working alliance. Furthermore, the 
therapists reported that for the majority of the clinical process, the telepsychology format 
faded to the background and that sessions were more similar to face-to-face treatment 
than different. Overall, it appears that the study was not negatively impacted by the 
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telepsychology format and rather, benefited participants who otherwise likely would not 
have received treatment.  
Limitations 
 Multiple considerations must be accounted for when interpreting the findings of 
the current study. As discussed, the use of telepsychology introduced difficulties not 
otherwise present in traditional clinical research, such as occasional lag in conversations, 
poor video quality, and an overall less controlled and more distracting environment. 
These factors reduced experimental control (internal validity) while increasing 
generalizability (external validity). Despite these concerns, the findings were consistent 
with face-to-face treatment. Telepsychology also reduced the ability for the therapist to 
notice and track physical changes in hair growth or notice the physical results of hair 
pulling between sessions. The video resolution simply did not allow the therapist to see 
these changes in any detail. This increased the reliance on participants to accurately 
report changes, decreasing experimental control. 
 The participant sample was diverse in some respects, but not others. The ratio of 
male to female participants was typical of trichotillomania research, with women over-
represented. The sample was somewhat diverse with regard to sexual orientation, 
education, marital status, income, and comorbid diagnoses, however, the vast majority 
(95.5%) of participants were White. While the current study was advertised online and at 
university counseling centers across Utah, the sample was heavily skewed in favor of 
White participants. The most recent census data describe 21.2% of Utah’s population as 
non-exclusively White (United States Census Beureau, 2016), thus, a more representative 
sample would be desired. Offering treatment only in English, likely contributed to this 
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issue. Future treatment studies should attempt to offer treatment in languages that meet 
the needs of the sample distribution’s demographic. Furthermore, treatment advertising 
efforts should better attempt to target more ethnically and racially diverse populations. 
For example, advertisements could be placed in community centers and hair care service 
locations that tend to serve minority populations. Very little trichotillomania research has 
examined non-White populations and this study, unfortunately, is no different. Increasing 
the ethnic and racial diversity of the sample would increase generalizability and allow for 
a better understanding of treatment in non-White populations. 
 As previously noted, item five of the VQ progress measure was missing from the 
assessment batteries at all time points, thus reducing the validity of the measure. All VQ 
progress-related outcomes should be interpreted with this in mind. The measure still 
displayed acceptable internal consistency, however. Additionally, the remaining four 
items consist of relatively face-valid phrases that appear to comprise much of the 
process’ intended meaning. 
 All outcome variables were obtained through client self-report, which was 
necessary for the study design, but prone to inaccuracies. Additionally, therapists were 
not blind to participant condition or assessment, which could potentially bias therapist 
behavior. However, no significant differences were found between the treatment and 
waitlist conditions on any measured variable, so this is unlikely. Finally, treatment was 
provided by only two therapists. This resulted in more experimental control by reducing 
variability in therapy presentation and quality, while at the same time reducing 
generalizability. Of note, no significant differences were found between the therapists 
and any outcome variable. 
   64
Future Directions 
 These initial findings provide a foundation for future telepsychotherapy 
trichotillomania treatment. Trichotillomania remains a challenging disorder to treat. 
Quality treatment is difficult to find, shame and guilt often act as barriers to seeking 
treatment, and when treated, gains in symptom improvement are difficult to maintain. 
Telepsychotherapy has the potential to ameliorate each of these concerns.  
As the popularity of telepsychology advances, individuals could be connected 
with quality therapists, trained in treating specific problems, such as trichotillomania. No 
longer will geographical location dictate the types of mental health services available to 
them. Moreover, for those with barriers to seeking treatment, telepsychology offers 
advantages over traditional face-to-face therapy. Individuals who avoid treatment due to 
difficult internal experiences such as shame, guilt, or anxiety may benefit from therapy 
that can be provided in their home. Furthermore, in-home treatment is convenient and 
may better serve time-constrained individuals or those without sufficient resources to 
travel to a clinic. 
 The telepsychology format is also well-suited to take advantage of modern 
technology that could potentially improve services and better maintain treatment gains. 
The current study only scraped the surface on this potential using a smartphone 
application that prompted participants to track daily behaviors of interest, such as number 
of hairs pulled, number of urges experienced, and values directed behavior. This simple 
tracking could be expanded upon and better tailored to individual clients to track 
behaviors specific to their concerns. Additionally, behavioral commitments made in 
session could be tracked and reported to a therapist as progress is made between sessions.  
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The use of these types of tools could also be extended following the conclusion of 
treatment and potentially aid in maintaining treatment gains. For example, therapists 
could maintain access to behaviors tracked and reported by clients following treatment. 
They could then occasionally contact clients to retrain or shape skills as needed. Modern 
technology provides the opportunity to rethink traditional treatment conventions, offering 
more individualized services to more people. Future research should explore this 
potential and expand on the foundation provided by this and other telepsychology-related 
research.    
   66
References 
 
Albers, C., & Lakens, D. (2017). Biased sample size estimates in a-priori power analysis 
due to the choice of the effect size index and follow-up bias. Journal of 
Experimental Social Psychology.  
Alcañiz, M., Botella, C., Baños, R., Perpiñá, C., Rey, B., Lozano, J. A., . . . Gil, J. A. 
(2003). Internet-based telehealth system for the treatment of agoraphobia. 
CyberPsychology & Behavior, 6(4), 355-358.  
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental 
disorders: DSM-IV-TR (4th ed.). Washington, DC: American Psychiatric 
Association. 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders: DSM-5™ (5th ed.). Arlington, VA, US: American Psychiatric 
Publishing, Inc. 
Andrews, B., Qian, M., & Valentine, J. D. (2002). Predicting depressive symptoms with a 
new measure of shame: The Experience of Shame Scale. British Journal of 
Clinical Psychology, 41(1), 29-42.  
Association, A. P. (2013). The Diagnostic and Statistical Manual of Mental Disorders: 
DSM 5: bookpointUS. 
Attkisson, C. C., & Zwick, R. (1982). The Client Satisfaction Questionnaire: 
Psychometric properties and correlations with service utilization and 
psychotherapy outcome. Evaluation and program planning, 5(3), 233-237. doi: 
10.1016/0149-7189(82)90074-X 
   67
Azrin, N. H., & Nunn, R. G. (1973). Habit-reversal: A method of eliminating nervous 
habits and tics. Behaviour Research and Therapy, 11(4), 619-628. doi: 
10.1016/0005-7967(73)90119-8 
Barnett, J. E., & Scheetz, K. (2003). Technological advances and telehealth: Ethics, law, 
and the practice of psychotherapy. Psychotherapy: Theory, Research, Practice, 
Training, 40(1-2), 86.  
Bate, K. S., Malouff, J. M., Thorsteinsson, E. T., & Bhullar, N. (2011). The efficacy of 
habit reversal therapy for tics, habit disorders, and stuttering: A meta-analytic 
review. Clinical Psychology Review, 31(5), 865-871. doi: 
10.1016/j.cpr.2011.03.013 
Bates, D., Maechler, M., Bolker, B., & Walker, S. (2015). Fitting Linear Mixed-Effects 
Models Using lme4. Journal of Statistical Software, 67(1), 1–48.  
Bloch, M. H., Landeros-Weisenberger, A., Dombrowski, P., Kelmendi, B., Wegner, R., 
Nudel, J., . . . Coric, V. (2007). Systematic review: pharmacological and 
behavioral treatment for trichotillomania. Biological Psychiatry, 62(8), 839-846.  
Bloch, M. H., Panza, K. E., Grant, J. E., Pittenger, C., & Leckman, J. F. (2013). N-
Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, 
double-blind, placebo-controlled add-on trial. Journal of the American Academy 
of Child & Adolescent Psychiatry, 52(3), 231-240.  
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., . . . 
Zettle, R. D. (2011). Preliminary psychometric properties of the Acceptance and 
Action Questionnaire–II: A revised measure of psychological inflexibility and 
experiential avoidance. Behavior Therapy, 42(4), 676-688.  
   68
Bouwer, C., & Stein, D. J. (1998). Trichobezoars in trichotillomania: case report and 
literature overview. Psychosomatic medicine, 60(5), 658-660.  
Burckhardt, C. S., & Anderson, K. L. (2003). The Quality of Life Scale (QOLS): 
reliability, validity, and utilization. Health and quality of life outcomes, 1(1), 60. 
doi: 10.1186/1477-7525-1-60 
Burckhardt, C. S., Anderson, K. L., Archenholtz, B., & Hägg, O. (2003). The Flanagan 
Quality of Life Scale: Evidence of Construct Validity. Health and quality of life 
outcomes, 1(1). doi: 10.1186/1477-7525-1-59 
Burckhardt, C. S., Woods, S. L., Schultz, A. A., & Ziebarth, D. M. (1989). Quality of life 
of adults with chronic illness: A psychometric study. Research in Nursing & 
Health, 12(6), 347-354. doi: 10.1002/nur.4770120604 
Capriotti, M. R., Ely, L. J., Snorrason, I., & Woods, D. W. (2015). Acceptance-Enhanced 
Behavior Therapy for Excoriation (Skin-Picking) Disorder in Adults: A Clinical 
Case Series. Cognitive and Behavioral Practice, 22(2), 230-239. doi: 
http://dx.doi.org/10.1016/j.cbpra.2014.01.008 
Chamberlain, S., Menzies, L., Sahakian, B., & Fineberg, N. (2007). Lifting the veil on 
trichotillomania. American Journal of Psychiatry, 164(4), 568-574.  
Chamberlain, S. R., Odlaug, B. L., Boulougouris, V., Fineberg, N. A., & Grant, J. E. 
(2009). Trichotillomania: Neurobiology and treatment. Neuroscience & 
Biobehavioral Reviews, 33(6), 831-842.  
Christenson, G. A., Mackenzie, T. B., & Mitchell, J. E. (1991a). Characteristics of 60 
adult hair pullers. The American Journal of Psychiatry.  
   69
Christenson, G. A., MacKenzie, T. B., & Mitchell, J. E. (1994). Adult Men and Women 
With Trichotilomania: A Comparison of Male and Female Characteristics. 
Psychosomatics, 35(2), 142-149.  
Christenson, G. A., Pyle, R. L., & Mitchell, J. E. (1991b). Estimated lifetime prevalence 
of trichotillomania in college students. Journal of Clinical Psychiatry, 52(10), 
415-417.  
Crosby, J. M., Dehlin, J. P., Mitchell, P. R., & Twohig, M. P. (2012). Acceptance and 
commitment therapy and habit reversal training for the treatment of 
trichotillomania. Cognitive and Behavioral Practice, 19(4), 595-605.  
Crosby, J. M., & Twohig, M. P. (2016). Acceptance and Commitment Therapy for 
Problematic Internet Pornography Use: A Randomized Trial. Behavior Therapy, 
47(3), 355-366.  
Dougherty, D. D., Loh, R., Jenike, M. A., & Keuthen, N. J. (2006). Single modality 
versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, 
or both? The Journal of clinical psychiatry, 67(7), 1086-1092.  
Dubose, J. A., & Spirrison, C. L. (2006). Hair Pulling in a Diverse College Sample. North 
American Journal of Psychology, 8(3).  
Duke, D. C., Keeley, M. L., Geffken, G. R., & Storch, E. A. (2010). Trichotillomania: A 
current review. Clinical Psychology Review, 30(2), 181-193.  
Falissard, B. (2012). Various procedures used in psychometry. https://CRAN.R-
project.org/package=psy. 
Fine, K. M., Walther, M. R., Joseph, J. M., Robinson, J., Ricketts, E. J., Bowe, W. E., & 
Woods, D. W. (2012). Acceptance-Enhanced Behavior Therapy for 
   70
Trichotillomania in Adolescents. Cognitive and Behavioral Practice, 19(3), 463-
471.  
Flessner, C. A., Busch, A. M., Heideman, P. W., & Woods, D. W. (2008a). Acceptance-
enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: 
Exploring the effects of component sequencing. Behavior Modification, 32(5), 
579-594. doi: 10.1177/0145445507313800 
Flessner, C. A., Conelea, C. A., Woods, D. W., Franklin, M. E., Keuthen, N. J., & 
Cashin, S. E. (2008b). Styles of pulling in trichotillomania: exploring differences 
in symptom severity, phenomenology, and functional impact. Behaviour Research 
and Therapy, 46(3), 345-357.  
Flessner, C. A., Woods, D. W., Franklin, M. E., Cashin, S. E., & Keuthen, N. J. (2008c). 
The Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version 
(MIST-A): Development of an instrument for the assessment of 'focused' and 
'automatic' hair pulling. Journal of Psychopathology and Behavioral Assessment, 
30(1), 20-30. doi: 10.1007/s10862-007-9073-x 
Fox, J., & Weisberg, S. (2011). An {R} companion to applied regression (2nd ed.). 
Thousand Oaks, CA: Sage. 
Franklin, M. E., Best, S. H., Wilson, M. A., Loew, B., & Compton, S. N. (2011). Habit 
reversal training and acceptance and commitment therapy for tourette syndrome: a 
pilot project. Journal of Developmental and Physical Disabilities, 23(1), 49-60. 
doi: 10.1007/s10882-010-9221-1 
Frueh, B. C., Henderson, S., & Myrick, H. (2005). Telehealth service delivery for persons 
with alcoholism. Journal of Telemedicine and Telecare, 11(7), 372-375.  
   71
Grady, B. J., & Melcer, T. (2005). A retrospective evaluation of telemental healthcare 
services for remote military populations. Telemedicine Journal & E-Health, 
11(5), 551-558.  
Grant, J. E., & Chamberlain, S. R. (2016). Trichotillomania. American Journal of 
Psychiatry, 173(9), 868-874.  
Grant, J. E., Odlaug, B. L., Schreiber, L. R., & Kim, S. W. (2014). The opiate antagonist, 
naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-
controlled study. Journal of Clinical Psychopharmacology, 34(1), 134-138.  
Grant, J. E., Redden, S. A., Medeiros, G. C., Odlaug, B. L., Curley, E. E., Tavares, H., & 
Keuthen, N. J. (2017). Trichotillomania and its clinical relationship to depression 
and anxiety. International journal of psychiatry in clinical practice, 1-5.  
Gros, D. F., Morland, L. A., Greene, C. J., Acierno, R., Strachan, M., Egede, L. E., . . . 
Frueh, B. C. (2013). Delivery of evidence-based psychotherapy via video 
telehealth. Journal of Psychopathology and Behavioral Assessment, 35(4), 506-
521.  
Gros, D. F., Yoder, M., Tuerk, P. W., Lozano, B. E., & Acierno, R. (2011). Exposure 
therapy for PTSD delivered to veterans via telehealth: Predictors of treatment 
completion and outcome and comparison to treatment delivered in person. 
Behavior Therapy, 42(2), 276-283.  
Hall, G. C. N. (2001). Psychotherapy research with ethnic minorities: empirical, ethical, 
and conceptual issues. Journal of Consulting and Clinical Psychology, 69(3), 502.  
Harley, J. (2006). Economic evaluation of a tertiary telepsychiatry service to an island. 
Journal of Telemedicine and Telecare, 12(7), 354-357.  
   72
Hatcher, R. L., & Gillaspy, J. A. (2006). Development and validation of a revised short 
version of the Working Alliance Inventory. Psychotherapy Research, 16(1), 12-
25.  
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance and 
Commitment Therapy: Model, processes and outcomes. Behaviour Research and 
Therapy, 44(1), 1-25. doi: 10.1016/j.brat.2005.06.006 
Hayes, S. C., Strosahl, K., Wilson, K. G., Bissett, R. T., Pistorello, J., Toarmino, D., . . . 
McCurry, S. M. (2004). Measuring experiential avoidance: A preliminary test of a 
working model. The Psychological Record, 54(4), 553-578. doi: 
10.1037/h0100908 
Hedman, E., Andersson, E., Ljótsson, B., Andersson, G., Rück, C., & Lindefors, N. 
(2011). Cost-effectiveness of Internet-based cognitive behavior therapy vs. 
cognitive behavioral group therapy for social anxiety disorder: results from a 
randomized controlled trial. Behaviour Research and Therapy, 49(11), 729-736.  
Himle, M. B., Freitag, M., Walther, M., Franklin, S. A., Ely, L., & Woods, D. W. (2012). 
A randomized pilot trial comparing videoconference versus face-to-face delivery 
of behavior therapy for childhood tic disorders. Behaviour Research and Therapy, 
50(9), 565-570.  
Himle, M. B., Olufs, E., Himle, J., Tucker, B. T. P., & Woods, D. W. (2010). Behavior 
therapy for tics via videoconference delivery: an initial pilot test in children. 
Cognitive and Behavioral Practice, 17(3), 329-337.  
Houghton, D. C., Capriotti, M. R., De Nadai, A. S., Compton, S. N., Twohig, M. P., 
Neal-Barnett, A. M., . . . Woods, D. W. (2015). Defining treatment response in 
   73
trichotillomania: a signal detection analysis. Journal of Anxiety Disorders, 36, 44-
51. doi: 10.1016/j.janxdis.2015.09.008 
Houghton, D. C., Compton, S. N., Twohig, M. P., Saunders, S. M., Frankli, M. E., Neal-
Barnett, A. M., . . . Woods, D. W. (2014). Measuring the Role of Psychological 
Inflexibility in Trichotillomania Psychiatry Research, 1-26.  
Keuthen, N. J., O'Sullivan, R. L., Ricciardi, J. N., & Shera, D. (1995a). The 
Massachusetts General Hospital (MGH) Hairpulling Scale: I. Development and 
factor analyses. Psychotherapy and Psychosomatics, 64(3-4), 141-145.  
Keuthen, N. J., O'Sullivan, R. L., Ricciardi, J. N., Shera, D., Savage, C. R., Borgmann, A. 
S., . . . Baer, L. (1995b). The Massachusetts General Hospital (MGH) Hairpulling 
Scale: I. Development and factor analyses. Psychotherapy and Psychosomatics, 
64(3-4), 141-145.  
Keuthen, N. J., Rothbaum, B. O., Falkenstein, M. J., Meunier, S., Timpano, K. R., Jenike, 
M. A., & Welch, S. S. (2010a). DBT-enhanced habit reversal treatment for 
trichotillomania: 3-and 6-month follow-up results. Depress. Anxiety, 28(4), 310-
313.  
Keuthen, N. J., Rothbaum, B. O., Welch, S. S., Taylor, C., Falkenstein, M., Heekin, 
M., . . . Fama, J. (2010b). Pilot trial of dialectical behavior therapy‐enhanced 
habit reversal for trichotillomania. Depression and Anxiety, 27(10), 953-959.  
Keuthen, N. J., & Sprich, S. E. (2012). Utilizing DBT skills to augment traditional CBT 
for trichotillomania: An adult case study. Cognitive and Behavioral Practice, 
19(2), 372-380.  
   74
King, R. A., Zohar, A. H., Ratzoni, G., Binder, M., Kron, S., Dycian, A., . . . Apter, A. 
(1995). An epidemiological study of trichotillomania in Israeli adolescents. 
Journal of the American Academy of Child & Adolescent Psychiatry, 34(9), 1212-
1215.  
Larsen, D. L., Attkisson, C. C., Hargreaves, W. A., & Nguyen, T. D. (1979). Assessment 
of client/patient satisfaction: development of a general scale. Evaluation and 
program planning, 2(3), 197-207. doi: 10.1016/0149-7189(79)90094-6 
Leonard, S. (2004). The development and evaluation of a telepsychiatry service for 
prisoners. Journal of Psychiatric and Mental Health Nursing, 11(4), 461-468.  
Lerner, J., Franklin, M. E., Meadows, E. A., Hembree, E., & Foa, E. B. (1999). 
Effectiveness of a cognitive behavioral treatment program for trichotillomania: an 
uncontrolled evaluation. Behavior Therapy, 29(1), 157-171.  
Lichstein, K. L., Scogin, F., Thomas, S. J., DiNapoli, E. A., Dillon, H. R., & McFadden, 
A. (2013). Telehealth cognitive behavior therapy for co‐occurring insomnia and 
depression symptoms in older adults. Journal of Clinical Psychology, 69(10), 
1056-1065.  
Maheu, M. M., Pulier, M. L., McMenamin, J. P., & Posen, L. (2012a). Future of 
telepsychology, telehealth, and various technologies in psychological research and 
practice. Professional Psychology: Research and Practice, 43(6), 613.  
Maheu, M. M., Pulier, M. L., McMenamin, J. P., & Posen, L. (2012b). Future of 
telepsychology, telehealth, and various technologies in psychological research and 
practice. Professional Psychology: Research and Practice, 43(6), 613-621.  
   75
Marcks, B. A., Wetterneck, C. T., & Woods, D. W. (2006). Investigating healthcare 
providers' knowledge of trichotillomania and its treatment. Cognitive Behaviour 
Therapy, 35(1), 19-27.  
McCarley, N. G., Spirrison, C. L., & Ceminsky, J. L. (2002). Hair pulling behavior 
reported by African American and non-African American college students. 
Journal of Psychopathology and Behavioral Assessment, 24(3), 139-144.  
Mitchell, J. E., & Callies, A. L. (1991). A Placebo-Controlled, Double-Blind Crossover 
Study of Fluoxetine in Trichotillomania. Am J Psychiatry, 148(1), 1567.  
Munder, T., Wilmers, F., Leonhart, R., Linster, H. W., & Barth, J. (2010). Working 
Alliance Inventory‐Short Revised (WAI‐SR): psychometric properties in 
outpatients and inpatients. Clinical Psychology & Psychotherapy, 17(3), 231-239.  
Neal, A. M., & Wilson, M. L. (1989). The role of skin color and features in the Black 
community: Implications for Black women and therapy. Clinical Psychology 
Review, 9(3), 323-333.  
Neal-Barnett, A., Flessner, C., Franklin, M. E., Woods, D. W., Keuthen, N. J., & Stein, 
D. J. (2010). Ethnic differences in trichotillomania: Phenomenology, interference, 
impairment, and treatment efficacy. Journal of Anxiety Disorders, 24(6), 553-558.  
Neal-Barnett, A., & Stadulis, R. (2006). Affective states and racial identity among 
African-American women with trichotillomania. Journal of the National Medical 
Association, 98(5), 753.  
Neal-Barnett, A. M., Ward-Brown, B. J., Mitchell, M., & Krownapple, M. (2000). Hair-
pulling in African Americans—Only your hairdresser knows for sure: An 
exploratory study. Cultural Diversity and Ethnic Minority Psychology, 6(4), 352.  
   76
Neal‐Barnett, A., Statom, D., & Stadulis, R. (2011). Trichotillomania symptoms in 
African American women: are they related to anxiety and culture? CNS 
neuroscience & therapeutics, 17(4), 207-213.  
Nelson, E.-L., Bui, T. N., & Velasquez, S. E. (2011). Telepsychology: Research and 
practice overview. Child and Adolescent Psychiatric Clinics of North America, 
20(1), 67-79.  
Ninan, P. T., Rothbaum, B. O., Marsteller, F. A., Knight, B. T., & Eccard, M. B. (2000). 
A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in 
trichotillomania. The Journal of clinical psychiatry, 61(1), 47-50.  
O'Sullivan, R., Keuthen, N., Hayday, C., Ricciardi, J., Buttolph, M., Jenike, M., & Baer, 
L. (1995). The Massachusetts General Hospital (MGH) Hairpulling Scale: 2. 
reliability and validity. Psychotherapy and Psychosomatics(64), 146-148.  
O'Sullivan, R. L., Keuthen, N. J., Jenike, M. A., & Gumley, G. (1996). Trichotillomania 
and carpal tunnel syndrome. The Journal of clinical psychiatry, 57(4), 174-174.  
Odlaug, B. L., & Grant, J. E. (2010). Impulse-control disorders in a college sample: 
results from the self-administered Minnesota Impulse Disorders Interview 
(MIDI). Primary care companion to the Journal of clinical psychiatry, 12(2).  
Odlaug, B. L., Kim, S. W., & Grant, J. E. (2010). Quality of life and clinical severity in 
pathological skin picking and trichotillomania. Journal of Anxiety Disorders, 
24(8), 823-829.  
Penzel, F. (2003). The Hair-Pulling Problem: A Complete Guide to Trichotillomania: A 
Complete Guide to Trichotillomania: Oxford University Press. 
   77
R Development Core Team. (2016). R: A language and environment for statistical 
computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved 
from https://www.R-project.org/ 
Rabinowitz, T., Murphy, K. M., Amour, J. L., Ricci, M. A., Caputo, M. P., & Newhouse, 
P. A. (2010). Benefits of a telepsychiatry consultation service for rural nursing 
home residents. Telemedicine and e-Health, 16(1), 34-40.  
Ragusea, A. S., & VandeCreek, L. (2003). Suggestions for the ethical practice of online 
psychotherapy (Vol. 40): Educational Publishing Foundation. 
Rangaswami, K. (1997). Management of a case of trichotillomania by cognitive 
behaviour therapy. Indian Journal of Clinical Psychology, 24, 89-92.  
Revelle, W. (2017). psych: Procedures for personality and psychological research., from 
https://CRAN.R-project.org/package=psych 
Rotondi, A. J., Haas, G. L., Anderson, C. M., Newhill, C. E., Spring, M. B., Ganguli, 
R., . . . Rosenstock, J. B. (2005). A Clinical Trial to Test the Feasibility of a 
Telehealth Psychoeducational Intervention for Persons With Schizophrenia and 
Their Families: Intervention and 3-Month Findings. Rehabilitation Psychology, 
50(4), 325-336.  
Savin, D., Garry, M. T., Zuccaro, P., & Novins, D. (2006). Telepsychiatry for treating 
rural American Indian Youth. Journal of the American Academy of Child & 
Adolescent Psychiatry, 45(4), 484-488.  
Schlosser, S., Black, D. W., Blum, N., & Goldstein, R. B. (1994). The demography, 
phenomenology, and family history of 22 persons with compulsive hair pulling. 
Annals of Clinical Psychiatry, 6(3), 147-152.  
   78
Selker, R., Love, J., & Dropmann, D. (2017). jmv: The 'jamovi' Analyses. from 
https://CRAN.R-project.org/package=jmv 
Shareh, H. (2017). A Preliminary Investigation of Metacognitive Therapy and Habit 
Reversal as a Treatment for Trichotillomania. Behavioural and cognitive 
psychotherapy, 1-20.  
Sharenow, E. L., Fuqua, R. W., & Miltenberger, R. G. (1989). The treatment of muscle 
tics with dissimilar competing response practice. Journal of Applied Behavior 
Analysis, 22(1), 35-42.  
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., . . . 
Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview 
(M.I.N.I.): The development and validation of a structured diagnostic psychiatric 
interview for DSM-IV and ICD-10. The Journal of clinical psychiatry, 59 (Suppl 
20), 22-33.  
Shingleton, R. M., Richards, L. K., & Thompson-Brenner, H. (2013). Using technology 
within the treatment of eating disorders: A clinical practice review. 
Psychotherapy, 50(4), 576-582.  
Siddiqui, E. U., Naeem, S. S., Naqvi, H., & Ahmed, B. (2012). Prevalence of body-
focused repetitive behaviors in three large medical colleges of Karachi: a cross-
sectional study. BMC research notes, 5(1), 614.  
Singh, S., Wetterneck, C. T., Williams, M. T., & Knott, L. E. (2016). The Role of Shame 
and Symptom Severity on Quality of Life in Obsessive-Compulsive and Related 
Disorders. Journal of Obsessive-Compulsive and Related Disorders. doi: 
http://dx.doi.org/10.1016/j.jocrd.2016.08.004 
   79
Smout, M., Davies, M., Burns, N., & Christie, A. (2014). Development of the Valuing 
Questionnaire (VQ). Journal of Contextual Behavioral Science, 3(3), 164-172.  
Sood, S., Mbarika, V., Jugoo, S., Dookhy, R., Doarn, C. R., Prakash, N., & Merrell, R. C. 
(2007). What is telemedicine? A collection of 104 peer-reviewed perspectives and 
theoretical underpinnings. Telemedicine and e-Health, 13(5), 573-590.  
Stanley, M. A., Borden, J. W., Bell, G. E., & Wagner, A. L. (1994). Nonclinical hair 
pulling: phenomenology and related psychopathology. Journal of Anxiety 
Disorders, 8(2), 119-130.  
Stemberger, R. M. T., Thomas, A. M., Mansueto, C. S., & Carter, J. G. (2000). Personal 
toll of trichotillomania: Behavioral and interpersonal sequelae. Journal of Anxiety 
Disorders, 14(1), 97-104.  
Streichenwein, S. M., & Thornby, J. I. (1995). A Long-Term, Double-Bhnd, Placebo-
Controlled Crossover Trial. Am J Psychiatry, 1, 52.  
Swedo, S. E., Leonard, H. L., Rapoport, J. L., Lenane, M. C., Goldberger, E. L., & 
Cheslow, D. L. (1989). A double-blind comparison of clomipramine and 
desipramine in the treatment of trichotillomania (hair pulling). New England 
Journal of Medicine, 321(8), 497-501.  
Trott, P., & Blignault, I. (1998). Cost evaluation of a telepsychiatry service in northern 
Queensland. Journal of Telemedicine and Telecare, 4(suppl 1), 66-68.  
Twohig, M., & Crosby, J. (2010a). Acceptance and Commitment Therapy as a Treatment 
for Problematic Internet Pornography Viewing. Behavior Therapy, 41(3), 285-
295.  
   80
Twohig, M. P., & Crosby, J. M. (2010b). Acceptance and Commitment Therapy as a 
Treatment for Problematic Internet Pornography Viewing. Behavior Therapy, 1-
11.  
Twohig, M. P., Hayes, S. C., & Masuda, A. (2006). A preliminary investigation of 
acceptance and commitment therapy as a treatment for chronic skin picking. 
Behaviour Research and Therapy, 44(10), 1513-1522.  
Twohig, M. P., & Woods, D. W. (2004). A preliminary investigation of acceptance and 
commitment therapy and habit reversal as a treatment for trichotillomania. 
Behavior Therapy, 35(4), 803-820.  
United States Census Beureau. (2016).   Retrieved 09/2017, from 
https://www.census.gov/quickfacts/UT 
Van Ameringen, M., Mancini, C., Patterson, B., Bennett, M., & Oakman, J. (2010). A 
randomized, double-blind, placebo-controlled trial of olanzapine in the treatment 
of trichotillomania. The Journal of clinical psychiatry, 71(10), 1336-1343.  
van Minnen, A., Hoogduin, K. A., Keijsers, G. P., Hellenbrand, I., & Hendriks, G.-J. 
(2003). Treatment of trichotillomania with behavioral therapy or fluoxetine: a 
randomized, waiting-list controlled study. Archives of General Psychiatry, 60(5), 
517-522.  
Walther, M. R., Ricketts, E. J., Conelea, C. A., & Woods, D. W. (2010). Recent advances 
in the understanding and treatment of trichotillomania. Journal of Cognitive 
Psychotherapy, 24(1), 46-64.  
Weingarden, H., & Renshaw, K. D. (2015). Shame in the obsessive compulsive related 
disorders: a conceptual review. Journal of Affective Disorders, 171, 74-84.  
   81
Welch, S. S., & Kim, J. (2012). DBT-enhanced cognitive behavioral therapy for 
adolescent trichotillomania: An adolescent case study. Cognitive and Behavioral 
Practice, 19(3), 483-493.  
Wetterneck, C. T., Woods, D. W., Norberg, M. M., & Begotka, A. M. (2006). The social 
and economic impact of trichotillomania: Results from two nonreferred samples. 
Behavioral Interventions, 21(2), 97-109.  
Wickham, H. (2017). tidyverse: Easily install and load 'Tidyverse' packages. R package 
version 1.1.1., from http://CRAN.R-project.org/package=tidyverse 
Woods, D. W., Flessner, C. A., Franklin, M. E., Keuthen, N. J., Goodwin, R. D., Stein, D. 
J., & Walther, M. R. (2006a). The Trichotillomania Impact Project (TIP): 
exploring phenomenology, functional impairment, and treatment utilization. 
Journal of Clinical Psychiatry, 67(12), 1877.  
Woods, D. W., Flessner, C. A., Franklin, M. E., Wetterneck, C. T., Walther, M. R., 
Anderson, E. R., & Cardona, D. (2006b). Understanding and Treating 
Trichotillomania: What We Know and What We Don't Know. Psychiatric Clinics 
of North America, 29(2), 487-501.  
Woods, D. W., Murray, L. K., Fuqua, R. W., Seif, T. A., Boyer, L. J., & Siah, A. (1999). 
Comparing the effectiveness of similar and dissimilar competing responses in 
evaluating the habit reversal treatment for oral–digital habits in children. Journal 
of Behavior Therapy and Experimental Psychiatry, 30(4), 289-300.  
Woods, D. W., & Twohig. (2008a). Trichotillomania an ACT-enhanced behavior therapy 
approach: therapist guide. Oxford; New York: Oxford University Press. 
   82
Woods, D. W., & Twohig, M. P. (2008b). Trichotillomania: An ACT-enhanced behavior 
therapy approach therapist guide: Oxford University Press. 
Woods, D. W., Wetterneck, C. T., & Flessner, C. A. (2006c). A controlled evaluation of 
acceptance and commitment therapy plus habit reversal for trichotillomania. 
Behaviour Research and Therapy, 44(5), 639-656.  
Zaylor, C., Whitten, P., & Kingsley, C. (2000). Telemedicine services to a county jail. 
Journal of Telemedicine and Telecare, 6(suppl 1), 93-95.  
 
 83 
 
 
 
 
 
 
 
 
 
 
Appendices 
  
   84
 
 
 
 
 
 
 
 
 
Appendix A 
Recruitment Flier   
   85
Research Study 
 
The Psychology Department at Utah State University  
is seeking individuals that struggle with… 
 
Trichotillomania  
or problematic hair pulling 
 
Do you pull out your hair and have been unable to stop? 
Is it difficult to control your pulling? 
Has it gotten in the way of your life? 
 
If you struggle with this problem, you may be eligible for participation in a study 
assessing the effectiveness of a psychological intervention provided over the 
internet (e.g. Skype). Participation requires no travel as the intervention will be 
provided in your home over the internet. The study will involve 12 hours of your 
time over six to nine months. There will be no compensation for participation, but 
involvement in the psychological intervention will be provided free of charge. If 
you are interested or have questions, please contact: 
 
Eric Lee 
(435) 797-8303 
eric.lee@aggiemail.usu.edu 
 
or 
 
Michael Twohig 
michael.twohig@usu.edu  
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TRICHOTILLOMANIA / TELEPSYCHOLOGY 
PHONE SCREENING FORM 
 
Date of Contact:_____________ 
Person completing phone screen:____________________________________________ 
Name:_________________________________________________________________ 
Primary Phone:_________________________________________(ok to LVM? No/Yes) 
Alternative Phone:_______________________________________(ok to LVM? No/Yes) 
Email:________________________________________________(ok to email? No/Yes) 
How old are you? (must be 18 or older) _____________________ 
Where do you live? (must reside in Utah) ____________________ 
Yes No  
  Are you comfortable receiving treatment in English? 
  Do you have access to a computer, tablet, or smart phone that can be used in a private location? 
  Do you have internet access? 
  Do you recurrently pull out your hair 
  Have you been unable to stop pulling despite attempts to do so? 
  Has this caused significant distress or impairment in your life? 
  Are you currently receiving psychotherapy? 
  Have you started or changed psychotropic medication in the past 30 days? 
  Are you planning to start or change psychotropic medication over the next nine months? 
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If eligible: 
(Explain study) 
• Treatment and waitlist groups 
• Intake plus 10 weekly sessions 
• Telepsychology 
• Services are free of charge 
What questions do you have about the study?  
It seems like this study is a good fit for you. Would you like to schedule an initial intake 
session?  
  Date & Time: ________________________________________________ 
  Reminder contact desired?:______________________________________ 
  What format?:  Email  
Text message – Primary Phone / Alt. Phone 
 
The intake session will be done over the internet using a program called VSee. I will 
email you step by step instructions on how to set this up on your computer/tablet/phone. I 
will also be available to walk you through any problems that you encounter with the set 
up over the phone. 
 
 
 
 
 
If ineligible: 
Unfortunately you are not eligible to participate in this study. Would you like any 
referrals at this time? Thank you for your time. 
Reason for ineligibility:______________________________________________ 
__________________________________________________________________ 
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Department of Psychology 
2810 Old Main Hill 
Logan, UT  84322  
(435) 797-1402 
Informed Consent 
 Telepsychotherapy for the Treatment of Trichotillomania:  
A Randomized Controlled Trial 
  
 
Introduction/ Purpose  Professor Michael P. Twohig, Ph.D. and Eric Lee in the 
Department of Psychology at Utah State University are conducting a study to find out 
more about the treatment of Trichotillomania. The goal of this study is to look at 
providing therapy for trichotillomania over the internet using video communication 
software (e.g., Skype). The therapy sessions will be very similar to face-to-face therapy, 
such as talking about your problem and doing exercises aimed at helping you gain greater 
control over this problem, except it will be done online. There will be no medication or 
other devices used in this treatment.  
 
You have been asked to take part in this study because you are at least 18 years old and 
have shown an interest in receiving treatment for trichotillomania. There will be up to 30 
participants enrolled in this study. 
 
Procedures  If you agree to participate, the following will happen: 
 
1) You will participate in a pretreatment interview over the internet and be asked to 
complete a short series of online surveys to help us understand your problem and to track 
how well the treatment works. 
 
2) You will be randomly placed in a treatment or wait list group. The treatment group 
will track their hair pulling for one week and then begin treatment immediately. The wait 
list group will track their hair pulling for one week and will then wait 12 weeks to begin 
treatment.  
 
3) When treatment begins, you will be asked to attend 10 weekly, online sessions (1 hour 
each) of therapy. Therapy will be about the way that you handle the urges to hair pull and 
will end with some exercises aimed at helping you stop pulling.  You will be asked to 
monitor hair pulling and record results to a provided secure website each day during 
treatment. You will be asked to complete a short online survey during each therapy 
session to help monitor progress. 
 
4) All of the treatment sessions will be recorded by video to allow us to make sure that 
the treatment is being done well. These videos will be stored on hard drives in a locked 
filing cabinet which only the investigators will have access to. Only the investigators will 
ever view these tapes. These recordings will be securely deleted when the investigation is 
completed. 
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5) If you immediately receive treatment you will be asked to complete the same 
assessments at your last treatment session that you completed the first time we met. If 
you are in the waitlist group we would like you to complete the packet after waiting 12 
weeks and again after treatment.  
 
6) You will be asked to complete these online assessments again, 12 weeks after you 
complete the treatment. All data identifiers will be destroyed when the study is 
completed. 
 
Alternative Procedures   Instead of participating in this research, an alternative for you 
to consider would be: receiving mental health services from a psychologist or 
psychiatrist, reading a self-help book on this topic, or from the website stoppulling.com 
or if you wish to explore other treatment options such as medical or other forms of 
therapy. We can provide referrals. 
 
New Findings:  You will be told of any important new findings (either good or bad), 
such as changes in the risks or benefits of being part of this study, or if there are different 
options to participating in this study that might cause you to change your mind about 
continuing in the study. If we learn new things about the study that are useful to you, or if 
the study changes at any time, you will be informed and we will ask you to complete a 
new consent form that will include the new information.  
 
Risks: Every effort will be made to keep physical, medical, psychological, social, legal, 
or other risks as low as possible. You could possibly feel mild discomfort from answering 
some of the questions or discussing your problem. The researchers will strive to minimize 
potential risks by keeping you well informed about the therapy process and debriefing as 
necessary. You will also be informed of alternative procedures or courses of treatment, if 
any, that might be advantageous for you. Further, you are free to withdraw your 
participation at any time or to not do any part of the study that you choose not to. There 
are no penalties for stopping or choosing to not do any part of the study. If you withdraw 
from the study or no longer attend scheduled sessions you will be asked to complete a 
post-treatment assessment at your discretion. All data that you provide and have 
previously provided will be de-identified, securely stored, and used in the study. All 
digital data will be collected and stored on secure servers. Video recordings of sessions 
and other physical data will be secured in a locked file cabinet in the Center for Clinical 
Research when not in use. Finally, while all precautions are being taken to keep 
information collected in this study confidential, the possibility exists that confidentiality 
may fail or have to be broken and information collected in this study could be seen by 
individuals not involved in this study.  
 
Benefits There may or may not be any direct benefit to you from these procedures. The 
most likely benefit from this participating in this study is a reduction in your hair pulling 
and a better understanding of trichotillomania. The investigator may learn more about 
ways to appropriately treat trichotillomania.  
 
Explanation & offer to answer questions: Professor Twohig or Eric Lee, has explained 
this research study to you and answered your questions. If you have other questions or 
   92
research-related problems, you may reach Professor Michael P. Twohig at (435) 797-
1402.   
 
Voluntary nature of participation and right to withdraw without consequence 
Participation in research is completely up to you. You may stop at any time you want, or 
you may skip any part of the study that you don’t want to do. Not completing part of the 
study will not affect your ability to participate in the rest of the study. 
 
Confidentiality  Research records will be kept confidential, consistent with federal and 
state regulations. Only the investigators and research assistants will have access to the 
data which will be kept in a locked file cabinet in a locked room.  All information 
collected in this study will be kept until the study is completed and then destroyed.  
 
Consistent with ethical guidelines for health professionals, confidentially may be 
breached in circumstances where either you or another person are in physical danger, or 
knowledge of harm, particularly children or the elderly, is relayed to the therapist. In 
these situations, reports will be made to the appropriate institutions or people.  
 
IRB Approval Statement The Institutional Review Board (IRB) for the protection of 
human participants at USU has reviewed and approved this research study.  If you have 
any pertinent questions or concerns about your rights or think the research may have 
harmed you, you may contact the IRB Director at (435) 797-0567 or email irb@usu.edu.  
If you have a concern or complaint about the research and you would like to contact 
someone other than the research team, you may contact the IRB Administrator to obtain 
information or to offer input. 
 
Investigator Statement “I certify that the research study has been explained to the 
individual, by me or my research staff, and that the individual understands the nature and 
purpose, the possible risks and benefits associated with taking part in this research study. 
Any questions that have been raised have been answered.”  
 
 
_______________________________  __________________________ 
Michael P. Twohig, Ph.D.               Eric B. Lee, M.A. 
Principal Investigator     Graduate Student Researcher 
(435) 797-1402     (435) 797-8303 
michael.twohig@usu.edu    eric.lee@aggiemail.usu.edu 
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Background Information 
 
1. How old are you? ____________ 
 
2. What is your marital status? 
 
1 = single  
2 = married  
3 = divorced  
4 = separated 
5 = remarried 
6 = widowed 
7 = cohabitating 
 
3. What was your sex at birth?  
 
1 = female 
2 = male 
 
4. Do you consider yourself to be transgender? 
 
 1 = Yes, transgender, male to female 
 2 = Yes, transgender, female to male 
 3 = Yes, transgender 
 4 = No 
 
5. What is your sexual orientation? 
 
 1 = heterosexual or straight 
 2 = gay or lesbian 
 3 = bisexual 
 4 = other 
 
6. What was the highest grade of school you completed? 
  
 Elementary     1  2  3  4  5  6  7  8 
 High School     9  10  11 12 GED 
 Post High School (vocational/technical) 1  2  3  4 
 College     1  2  3  4 degree? ______ 
 Graduate/Professional    5  6  7  8 degree? ______ 
 
7. Are you Hispanic or Latino?  
 
 1 = No not Hispanic or Latino 
 2 = Yes, Hispanic or Latino 
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8. How would you describe yourself?  
(Choose one or more from the following racial groups) 
 
1 = American Indian or Alaska Native 
 2 = Asian 
3 = Black or African American 
4 = Native Hawaiian or Other Pacific Islander 
5 = White or European American 
 
9. What is your monthly household gross income? 
 
 1 = less than $1,000 
 2 = $1,000–$1,999 
 3 = $2,000–$2,999 
 4 = $3,000–$3,999 
 5 = $4,000–$4,999 
 6 = $5,000–$5,999 
 7 = $6,000–$6,999 
 8 = $7,000–$7,999 
 9 = $8,000–$8,999 
 10 = $9,000–$9,999 
 11 = more than $10,000 
 
10. How long have you been pulling your hair out?  
 
 
 
11. How long has this been a problem for you?  
 
 
 
12. Have you ever sought treatment or tried other procedures?  If yes, what did you try? 
 
 
 
13. Have you ever been diagnosed with any psychological disorders? If yes, please list. 
 
 
 
14. Are you on any psychotropic medications or have you been on any in the last 6 
months?  If yes please list and tell me when you started your most recent dosage.   
 
 
 
15. Do you ever ingest your hair after pulling it out? 
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16. Would you be seeking services for your hair pulling if it was not provided over the 
internet? 
 
 
 
17. Do you have any circumstances that would inhibit you from attending face-to-face 
therapy? 
 Busy schedule 
 Treatment for trichotillomania is not provided near me 
 Lack of money (for example: gas, bus fare) 
 Lack of resources (for example: car, ride from friend of family) 
 Physical disability 
 Discomfort from leaving your home 
  Leaving my home: 
   Frightens me (anxiety) 
   Is too much effort (depression) 
   Makes me feel judged by others (shame) 
 
 
18. For what reasons are you participating in this study? 
 No cost therapy 
 I prefer receiving therapy over the internet 
 I have been unable to find therapist near me who understands trichotillomania 
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Massachusetts General Hospital Hair Pulling Scale 
 
Instructions:  For each question, pick the one statement in that group which best describes 
your behaviors and/or feelings over the past week.  If you have been having ups and 
downs, try to estimate an average for the past week.  Be sure to read all of the statements 
in each group before making your choice. 
 
For the next three questions, rate only the urges to pull your hair. 
 
1. Frequency of urges.  On an average day, how often did you feel the urge to pull 
your hair? 
0 This week I felt no urges to pull my hair. 
1 This week I felt an occasional urge to pull my hair. 
2 This week I felt an urge to pull my hair often. 
3 This week I felt an urge to pull my hair very often. 
4 This week I felt near constant urges to pull my hair. 
 
2. Intensity of urges.  On an average day, how intense or ‘strong’ were the urges to 
pull your hair? 
0 This week I did not feel any urges to pull my hair 
1 This week I felt mild urges to pull my hair 
2 This week I felt moderate urges to pull my hair 
3 This week I felt severe urges to pull my hair. 
4 This week I felt extreme urges to pull my hair. 
 
3. Ability to control the urges.  On an average day, how much control do you have 
over the urges to pull your hair? 
0 This week I could always control the urges, or I did not feel urges to pull 
my hair. 
1 This week I was able to distract myself from the urges to pull my hair 
most of the time. 
2 This week I was able to distract myself from the urges to pull my hair 
some of the time. 
3 This week I was able to distract myself from the urges to pull my hair 
rarely. 
4 This week I was never able to distract myself from the urges to pull my 
hair. 
 
 
For the next three questions, rate only the actual hairpulling 
 
4. Frequency of hairpulling.  On an average day, how often did you actually pull 
your hair? 
0 This week I did not pull my hair. 
1 This week I pulled my hair occasionally. 
2 This week I pulled my hair often. 
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3 This week I pulled my hair very often. 
4 This week I pulled my hair so often it felt like I was always doing it. 
 
5. Attempts to resist hairpulling.  On an average day, how often did you make an 
attempt to stop yourself from actually pulling your hair? 
0 This week I felt no urges to pull my hair. 
1 This week I tried to resist the urge to pull my hair almost all of the time. 
2 This week I tried to resist the urge to pull my hair some of the time. 
3 This week I tried to resist the urge to pull my hair rarely. 
4 This week I never tried to resist the urge to pull my hair. 
 
6. Control over hairpulling.  On an average day, how often were you successful at 
actually stopping yourself from pulling your hair? 
0 This week I did no pull my hair. 
1 This week I was able to resist pulling my hair almost all of the time 
2 This week I was able to resist pulling my hair most of the time. 
3 This week I was able to resist pulling my hair some of the time. 
4 This week I was rarely able to resist pulling my hair. 
 
 
For the last question, rate the consequences of your hairpulling. 
 
7. Associated distress.  Hairpulling can make some people feel moody, ‘on edge’, or 
sad.  During the past week, how uncomfortable did your hairpulling make you 
feel? 
0 This week I did not feel uncomfortable about my hairpulling. 
1 This week I felt vaguely uncomfortable about my hairpulling. 
2 This week I felt noticeably uncomfortable about my hairpulling. 
3 This week I felt significantly uncomfortable about my hairpulling. 
4 This week I felt intensely uncomfortable about my hairpulling. 
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Quality of Life Scale 
 
Please read each item and circle the number that best describes how satisfied you are at 
this time. Please answer each item even if you do not currently participate in an activity 
or have a relationship. You can be satisfied or dissatisfied with not doing the activity or 
having the relationship. 
1.  Material comforts, home, food, conveniences, financial security 
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
2.  Health - being physically fit and vigorous 
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
3.  Relationships with parents, siblings & other relatives - communicating, visiting, 
helping  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
4.  Having and rearing children  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
5.  Close relationship with spouse or significant other? 
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
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6.  Close friends  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
7.     Helping and encouraging others, volunteering, giving advice  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
8.  Participating in organizations and public affairs  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
9.  Learning- attending school, improving understanding, getting additional knowledge  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
10.  Understanding yourself – knowing your assets and limitations – knowing what life is 
about   
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
11.  Work – job or in home  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
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12.  Expressing yourself creatively  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
13.  Socializing – meeting other people, doing things, parties, etc.  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
14.  Reading, listening to music or observing entertainment  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
15.  Participating in active recreation  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
 
16.  Independence, doing for yourself  
7 6 5 4 3 2 1 
Delighted Pleased Mostly 
Satisfied 
Mixed Mostly 
Dissatisfied 
Unhappy Terrible 
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Appendix E 
Treatment Outline 
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Session 
Treatment 
Components 
Exercises/Content 
1 Informed Consent  • Review potential risks of treatment (e.g., emotional 
discomfort) 
• Discuss added risks of telepsychology (e.g., reduced 
guarantee of confidentiality, privacy issues) 
Limits to 
Confidentiality 
• Risk of harming self or others and abuse of children or 
elderly 
  
Psychoeducation 
and Treatment 
Overview  
• Basics of trichotillomania, behavioral model, 
environmental triggers, emotional and cognitive factors 
related to pulling. 
• Brief overview of what is to be expected throughout 
treatment 
Stimulus Control 
Assessment 
• Stimulus Control Assessment Form 
• Introduce self-monitoring. Assign homework to 
monitor hair pulling during the coming week 
2 Habit Reversal 
Training 
 
 
Stimulus Control 
• Awareness training 
• Competing response training 
 
• Stimulus Control Assignment Sheet 
• Identify individualized stimulus control techniques to 
be used in different contexts where pulling is more 
likely to occur 
3 Valuing • Define values. Discuss differences with goals 
• Complete How Has Fighting Your Urges Affected You 
and Writing Your Epitaph forms 
• Discuss how attempts to control pulling have gotten in 
the way of valued living 
4 Creative 
Hopelessness and 
the Control Agenda 
• Continue discussion of barriers to pursuing values 
• Help the client see how futile and damaging the control 
agenda is: 
•      What is currently being done to control urges? 
•      How well do these strategies work in the short-
term? 
•      How well do they work in the long-term? 
•      Discuss costs associated with the current strategies 
•      Is the struggle with the urge becoming larger or 
smaller? 
• Two-Games metaphor 
• Homework: Assign Paper in Shoe exercise 
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5 Acceptance • Examples of our inability to control bodily sensations, 
emotions, thoughts, as well as urges to pull 
• Discuss Paper in Shoe exercise 
• Introduce willingness as an alternative to the control 
agenda 
• Clarify the acceptance of urges verses the acceptance 
of non-valued behavior 
Behavioral 
Commitments 
• Develop behavioral commitment exercises to practice 
skills outside of session 
• Opportunities to follow values instead of controlling 
urges 
• Success is determined by whether task is completed, 
not by the levels of urges or distress 
• Openness to experience, not tolerance 
•      Behavioral Commitment Worksheet 
6–7 Defusion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Behavioral 
Commitments 
• Discussion about our minds not always acting in our 
best interest 
• Present various defusion exercises in an attempt to 
undermine the literality of language and the negative 
effects due to this 
• The number of exercises and order given are at the 
discretion of the therapist 
•      Being Present 
•      Tree-on-the-Road Metaphor 
•      Acting without Reasons 
•      Playing with Urges in a Different Way 
•      Evaluation versus Description 
•      The Pull of Your Mind 
•      Take Your Urges with You 
•      Talking for the Client 
 
• Agree to engage in new behavior commitment exercise 
in addition to previous ones 
8 Acceptance and 
Defusion as Skills 
 
 
 
 
 
 
Behavioral 
Commitments 
• In-session exposure exercises 
• Done in attempt to “make friends” with the urges, not 
necessarily reduce them 
• During these exercises the therapist will review 
acceptance, defusion, and values in the moment, as 
needed 
 
• Ask the client to complete Making Friends with Your 
Urges worksheet before next session 
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• Agree to engage in new behavior commitment exercise 
in addition to previous ones 
9 Practicing ACT 
Skills 
 
Relapse Prevention 
 
Behavioral 
Commitments 
• Continue with in-session exposure exercises 
• Allow them to practice ACT skills 
 
• Ask the client to review the therapy up to this point 
• Review important topics that have been discussed in 
past sessions 
 
• Agree to engage in new behavior commitment exercise 
in addition to previous ones 
10 Review 
 
 
 
Relapse Prevention 
 
 
Celebrate 
Accomplishments 
• Discuss and review what has been learned throughout 
therapy 
• Review areas of importance for the client and clarify 
areas where the client might be confused 
 
• Discus lapse versus relapse 
• Vigilance in using habit reversal training 
• Increase in cognitive fusion 
• Returning to old agenda 
 
• Congratulate client on their progress 
• Answer any questions about future issues 
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